Protection of neurons in vitro and in vivo from Synuclein toxicity by molecular tweezers
Lead Research Organisation:
University of Oxford
Department Name: Physiology Anatomy and Genetics
Abstract
Parkinson's disease is an age-related neurodegenerative disorder in which aggregated clumps of a protein termed alpha-synuclein form in neurons, the cells in the brain which relay electrical information. These clumps are the defining key hallmark pathology of Parkinson's and are called Lewy bodies (LB). In a related disease, multiple system atrophy (MSA), the protein clumps form in the support cells, called glia. The diseases are therefore related and may benefit from a therapy to prevent the formation and spread of alpha-synuclein protein clumps.
The development of therapeutic strategies to prevent the formation and spread of alpha-synuclein protein clumps and prevent cell death in Parkinson's and MSA has been limited by a lack of understanding of the mechanisms driving neurodegeneration. However, increasing evidence demonstrates the importance of the alpha-synuclein clumps in disease pathology and has led to consider the therapeutic potential of several strategies aimed at reducing the burden and toxicity of alpha-synuclein accumulation. Our objective here is to build upon the unique experimental models of disease and complementary expertise of the Consortium. Members of the research team specialise in working in brain cells from mice, and with human neurons derived from stem cells made from Parkinson's patients. Others members of the team work on animal models of Parkinson's and MSA which model how alpha-synuclein may spread in the brain. We will use these models in laboratories in France and in the UK to test a novel molecular therapy called "molecular tweezer" drug which has been shown to inhibit aggregation and toxicity of other similar proteins which clump in other diseases. The drug may therefore protect neurons grown in the laboratory and neurons in the brain from Parkinson's or MSA-associated cell death. By probing the mechanisms and application of "molecular tweezers" to Parkinson's and MSA the project will demonstrate the use or not of such a therapy to prevent alpha-synuclein-mediated cell death.
The development of therapeutic strategies to prevent the formation and spread of alpha-synuclein protein clumps and prevent cell death in Parkinson's and MSA has been limited by a lack of understanding of the mechanisms driving neurodegeneration. However, increasing evidence demonstrates the importance of the alpha-synuclein clumps in disease pathology and has led to consider the therapeutic potential of several strategies aimed at reducing the burden and toxicity of alpha-synuclein accumulation. Our objective here is to build upon the unique experimental models of disease and complementary expertise of the Consortium. Members of the research team specialise in working in brain cells from mice, and with human neurons derived from stem cells made from Parkinson's patients. Others members of the team work on animal models of Parkinson's and MSA which model how alpha-synuclein may spread in the brain. We will use these models in laboratories in France and in the UK to test a novel molecular therapy called "molecular tweezer" drug which has been shown to inhibit aggregation and toxicity of other similar proteins which clump in other diseases. The drug may therefore protect neurons grown in the laboratory and neurons in the brain from Parkinson's or MSA-associated cell death. By probing the mechanisms and application of "molecular tweezers" to Parkinson's and MSA the project will demonstrate the use or not of such a therapy to prevent alpha-synuclein-mediated cell death.
Technical Summary
Parkinson disease (PD) is hallmarked by the deposition of aggregated alpha-synuclein (alpha-syn) species into intra-neuronal Lewy bodies (LB) and Lewy neurites (LN) inclusions while in multiple system atrophy (MSA) alpha-syn aggregates form oligodendroglial inclusions. The development of therapeutic strategies to block cell death in PD and MSA has been limited by a lack of understanding of the mechanisms driving neurodegeneration. However, increasing evidence of multiple pivotal roles of alpha-syn in the pathogenesis of PD and MSA has led to consider the therapeutic potential of several strategies aimed at reducing alpha-synuclein toxicity. Our objective is to build upon the unique experimental cell (Primary rodent neurons and glial cells - Human neurons derived from PD patients) and animal models of PD (SNCAOVX transgenic mouse and human PD-derived alpha-syn seed-injected mouse) and MSA (PLP-SYN transgenic mouse and human MSA-derived alpha-syn seed-injected mouse), developed by this consortium, for testing whether the prototypical molecular tweezer CLR01, shown to inhibit aggregation and toxicity of other amyloidogenic proteins, could protect neurons in vitro and in vivo from PD / MSA-associated synaptotoxicity and reduce PD and MSA's disease-like alpha-syn pathology. The project will thus (in)validate the molecular tweezers CLR01 for PD and/or MSA indications.
Planned Impact
The project will foster the development of disease-modifying treatment. To this end, it will develop and characterize a novel innovative molecule (CLR01) in clinically relevant human patient-derived dopaminergic neurons and in novel animal models to study its ability to interfere with alpha-syn pathology that it is induced by increased expression or by pathophysiological spread of patient-derived alpha-syn assemblies.
The synergy between the three complementary laboratories will maximize the potential for achieving these goals. We will efficiently share and transfer key materials, protocols and data between our laboratories, raising the chances of yielding synergistic, interdisciplinary, and groundbreaking research results. Hence, the outcome will be more than the arithmetic sum of each of our respective expertise, working force and the respective local academic environments. The multidisciplinary aspect of the project is essential to its objectives. It will benefit from expertise in many disciplines within neuroscience, delineating a clear synergistic network of competencies. Not only are different complementary capabilities needed to succeed, but a truly synergistic framework is mandatory. Our newly established links will allow implementing an innovative way of synergic work. The immediate potential impact on both academic and industrial research domains aiming at developing neuroprotective treatments justifies accepting this challenge, as success of this grant would increase Europe competitiveness in an area of neuroscience and neurology which is under high demand and expectation for newer and more efficacious therapeutic approaches.
The synergy between the three complementary laboratories will maximize the potential for achieving these goals. We will efficiently share and transfer key materials, protocols and data between our laboratories, raising the chances of yielding synergistic, interdisciplinary, and groundbreaking research results. Hence, the outcome will be more than the arithmetic sum of each of our respective expertise, working force and the respective local academic environments. The multidisciplinary aspect of the project is essential to its objectives. It will benefit from expertise in many disciplines within neuroscience, delineating a clear synergistic network of competencies. Not only are different complementary capabilities needed to succeed, but a truly synergistic framework is mandatory. Our newly established links will allow implementing an innovative way of synergic work. The immediate potential impact on both academic and industrial research domains aiming at developing neuroprotective treatments justifies accepting this challenge, as success of this grant would increase Europe competitiveness in an area of neuroscience and neurology which is under high demand and expectation for newer and more efficacious therapeutic approaches.
Organisations
- University of Oxford (Lead Research Organisation)
- ASTON UNIVERSITY (Collaboration)
- University of Porto (Collaboration)
- University of Oslo (Collaboration)
- UK Dementia Research Institute (Collaboration)
- Wellcome Trust (Collaboration)
- The International Parkinson Disease Genomics Consortium (Collaboration)
- University of Southern Denmark (Collaboration)
- JPND Research (Collaboration)
- UNIVERSITY OF OXFORD (Collaboration)
- Achucarro Basque Center for Neuroscience (Collaboration)
- National Institute on Aging (Collaboration)
- UNIVERSITY OF GLASGOW (Collaboration)
- University of the Basque Country (Collaboration)
- University of Bordeaux (Collaboration)
- National Institutes of Health (NIH) (Collaboration)
- Medical Research Council (MRC) (Collaboration)
People |
ORCID iD |
Richard Wade-Martins (Principal Investigator) |
Publications
Agarwal D
(2020)
A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders.
in Nature communications
Alegre-Abarrategui J
(2019)
Selective vulnerability in a-synucleinopathies.
in Acta neuropathologica
Aman Y
(2020)
Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases.
in International review of neurobiology
Bauermeister S
(2020)
The Dementias Platform UK (DPUK) Data Portal.
in European journal of epidemiology
Bengoa-Vergniory N
(2021)
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.
in Acta neuropathologica communications
Bengoa-Vergniory N
(2021)
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease
in Acta Neuropathologica Communications
Bengoa-Vergniory N
(2017)
Identification of Noncanonical Wnt Receptors Required for Wnt-3a-Induced Early Differentiation of Human Neural Stem Cells.
in Molecular neurobiology
Bengoa-Vergniory N
(2017)
Alpha-synuclein oligomers: a new hope.
in Acta neuropathologica
Bengoa-Vergniory N
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease (accepted 2020)
in Acta Neuropathologica Communications
Bengoa-Vergniory N
(2020)
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease.
in Nature communications
Bengoa-Vergniory N
(2016)
The stem cell cocktail: neural reprogramming just got easier.
in Stem cell investigation
Bogetofte H
(2023)
Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.
in Cell reports
Burley S
(2022)
Hyperexcitability in young iPSC-derived C9ORF72 mutant motor neurons is associated with increased intracellular calcium release.
in Scientific reports
Butkovich LM
(2020)
Transgenic Mice Expressing Human a-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
in The Journal of neuroscience : the official journal of the Society for Neuroscience
Caiazza M
(2020)
Recent Advances in Parkinson's Disease
Carling PJ
(2020)
Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease.
in Progress in neurobiology
Cramb KML
(2023)
Impaired dopamine release in Parkinson's disease.
in Brain : a journal of neurology
Doucet M
(2017)
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
in PLOS ONE
Emmenegger M
(2021)
LAG3 is not expressed in human and murine neurons and does not modulate a-synucleinopathies.
in EMBO molecular medicine
Fdez E
(2022)
Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacement.
in iScience
Fields CR
(2019)
Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.
in Frontiers in molecular neuroscience
Griffanti L
(2020)
Cohort profile: the Oxford Parkinson's Disease Centre Discovery Cohort MRI substudy (OPDC-MRI).
in BMJ open
Hasan S
(2023)
Multi-modal Proteomic Characterization of Lysosomal Function and Proteostasis in Progranulin-Deficient Neurons.
in bioRxiv : the preprint server for biology
Description | Dr Dayne Beccano-Kelly became a member of the Equality Diversity and Inclusion Task force for The Physiological Society |
Geographic Reach | Europe |
Policy Influence Type | Membership of a guideline committee |
URL | https://www.physoc.org/about-us/diversity/ |
Description | Kamina Naidoo is a mentor for the BiPOC Stem network THRIVE scheme |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Contribution to new or improved professional practice |
URL | https://bipocstemnetwork.web.ox.ac.uk/ |
Description | A*-STAR Scholarship (Supervisor to Quyen Do). Advanced 3D co-culture iPSC-derived models of Parkinson's |
Amount | $206,382 (SGD) |
Organisation | Agency for Science, Technology and Research (A*STAR) |
Sector | Public |
Country | Singapore |
Start | 01/2018 |
End | 09/2022 |
Description | ARUK Illustration Award 2021 given to Bryan Ng |
Amount | £200 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 04/2021 |
End | 08/2021 |
Description | ARUK Illustration Award 2023 given to Ajantha Abey |
Amount | £200 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 05/2023 |
Description | ARUK Illustration Award 2023 given to Rachel Heon Roberts |
Amount | £200 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 05/2023 |
Description | ARUK Pilot Award 2020-21 given to Dr Charmaine Lang & Mr Peter Kilfeather |
Amount | £2,297 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2021 |
End | 08/2021 |
Description | ARUK Pilot Award 2020-21 given to Maria Claudia Caiazza |
Amount | £2,500 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2021 |
End | 08/2021 |
Description | ARUK Thames Valley Network Pilot Award 2022 |
Amount | £2,000 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2022 |
End | 12/2023 |
Description | ARUK Thames Valley Network Travel Award for Becky Carlyle |
Amount | £168 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 08/2022 |
End | 12/2022 |
Description | ARUK Thames Valley Network Travel Award for Brent Ryan to attend two conferences |
Amount | £54,095 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2022 |
End | 12/2022 |
Description | ARUK Thames Valley Network Travel Award for Helle Barknob |
Amount | £138 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 11/2022 |
End | 12/2022 |
Description | ARUK Thames Valley Network Travel Award for Hugo Fernandes |
Amount | £211 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 08/2022 |
End | 02/2023 |
Description | ARUK Thames Valley Network Travel Award for Maria Claudia Caiazza |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2022 |
End | 12/2022 |
Description | ARUK Thames Valley Network Travel Award for Rachel Heon Roberts |
Amount | £600 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2022 |
End | 01/2023 |
Description | ARUK Thames Valley Network Travel Award for William McGuinness |
Amount | £500 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2022 |
End | 01/2023 |
Description | ARUK Thames Valley Network travel award: Mootaz Salman |
Amount | £600 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2022 |
End | 12/2023 |
Description | ARUK Travel Award 2020-21 given to Kaitlyn Cramb to attend & present at AD/PD conference in Barcelona |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2022 |
End | 03/2022 |
Description | ARUK Travel Award 2020-21 given to Martha Lavelle |
Amount | £100 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 08/2021 |
End | 09/2021 |
Description | ARUK Travel Award 2020-21 given to Quyen Do to attend Ion channels in Synaptic and Neural Circuit Physiology online conference |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 05/2021 |
End | 06/2021 |
Description | ARUK Travel Award given to Ajantha Abey to attend ARUK Early Careers Day and Research Conference 2022 |
Amount | £126 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2022 |
End | 03/2022 |
Description | ARUK Travel Award given to Ajantha Abey to attend ARUK Early Careers Day and Research Conference 2023 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to Akansha Mehta to attend ARUK Research Conference 2023 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to Bryan Ng to attend ARUK Early Careers Day and Research Conference 2022 |
Amount | £205 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2022 |
End | 03/2022 |
Description | ARUK Travel Award given to Charmaine Lang to attend ARUK Research Conference 2023 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to Gizem Onal to attend ARUK Research Conference 2023 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to Jonah-Wolf Schreier to attend ARUK Research Conference 2023 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to Kaitlyn Cramb to attend Federation of European Neuroscience Societies Regional Meeting 2023 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2023 |
End | 05/2023 |
Description | ARUK Travel Award given to Maria Claudia Caiazza to attend AD/PD conference 2022 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2022 |
End | 03/2022 |
Description | ARUK Travel Award given to Maria Claudia Caiazza to attend Parkinson's Disease Theme ECR workshop Meeting 2023 |
Amount | £204 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to Mootaz Salman to attend ARUK Research Conference 2023 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to Mootaz Salman to attend Brain 2022 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 04/2022 |
End | 07/2022 |
Description | ARUK Travel Award given to Nancy Ahuja to attend ARUK Research Conference 2023 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to Naroa Ibarra Aizpurua to attend UKDRI - Parkinson's Disease Theme ECR Workshop 2023 |
Amount | £96 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 03/2023 |
Description | ARUK Travel Award given to William McGuinness to attend AD/PD conference 2022 |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2022 |
End | 03/2022 |
Description | ARUK Travel grant |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 07/2019 |
End | 08/2019 |
Description | Ajantha Abey, The Clarendon Fund & Department of Physiology, Anatomy, and Genetics Scholarship. Project title: Understanding Selective Neuronal Vulnerability in Alzheimer's and Parkinson's Disease and Potential Remedies Through Patient-Derived Stem-Cells |
Amount | £125,097 (GBP) |
Organisation | University of Oxford |
Sector | Academic/University |
Country | United Kingdom |
Start | 09/2020 |
End | 09/2023 |
Description | Awarded an Oxford ARUK Small Equipment Award to purchase an Oxford Nanopore MinION |
Amount | £3,670 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2019 |
End | 07/2019 |
Description | Becky Carlyle - Subcellular proteomic signatures of Alzheimer's disease. |
Amount | $64,000 (USD) |
Organisation | National Institutes of Health (NIH) |
Sector | Public |
Country | United States |
Start | 01/2022 |
End | 12/2024 |
Description | Compartmentalised calcium handling in dopamine neurons: importance for selective vulnerability in Parkinson's. |
Amount | £3,700,000 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 04/2022 |
End | 04/2027 |
Description | Dayne Beccano-Kelly Lockey Fund- for travel to World Parkinson's congress |
Amount | £500 (GBP) |
Organisation | Lockey Committee |
Sector | Academic/University |
Country | United Kingdom |
Start | 02/2019 |
End | 04/2019 |
Description | Dept MRC Studentship (Principal Supervisor to Naroa Ibarra Aizpurua, Co-supervisor Dr Sally Cowley; Understanding the contribution of astrocytes to Parkinson's. |
Amount | £15,900 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2020 |
End | 09/2022 |
Description | Developing new therapeutic drugs in pre-clinical models of Parkinson's. |
Amount | $200,000 (USD) |
Organisation | Michael J Fox Foundation |
Sector | Charity/Non Profit |
Country | United States |
Start | 06/2021 |
End | 02/2023 |
Description | Dr Andrea Loreto Sir Henry Wellcome postdoctoral fellowship. Project title: The role of the Wallerian axon-death pathway in neuronal and axonal vulnerability in Parkinson's disease |
Amount | £250,000 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2021 |
End | 04/2022 |
Description | Dr Becky Carlyle: Exploiting sub-cellular proteomics and high-throughput validation screens to define the role of proteome complexity in Alzheimer's Disease |
Amount | £420,000 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2022 |
End | 09/2025 |
Description | Dr Charmaine Lang & Mr Peter Kilfeather were awarded an ARUK Thames Valley Pilot Award |
Amount | £2,297 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2021 |
End | 06/2021 |
Description | Dr Mootaz Salman was awarded an ARUK Thames Valley Network Small Equipment Award 2020 |
Amount | £2,000 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 12/2020 |
End | 03/2021 |
Description | Dr Phillipa Carling was awarded an ARUK Thames Valley Network ECR award |
Amount | £349 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 05/2020 |
End | 12/2020 |
Description | Dr Stefania Giussani was awarded an ARUK Thames valley network ECR Award |
Amount | £493 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 05/2020 |
End | 12/2020 |
Description | ECR grant award for Bryan Ng |
Amount | £425 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 05/2020 |
End | 03/2021 |
Description | Elliot Mock - Validation of USP14 as a therapeutic target in Parkinson's disease. |
Amount | £150,000 (GBP) |
Organisation | Netherlands Organisation for Scientific Research (NWO) |
Sector | Public |
Country | Netherlands |
Start | 09/2021 |
End | 09/2023 |
Description | FENS travel award for Bryan Ng |
Amount | € 75 (EUR) |
Organisation | Federation of European Neuroscience Societies (FENS) |
Sector | Private |
Country | Belgium |
Start | 06/2020 |
End | 07/2020 |
Description | Functional screening of Parkinson's GWAS loci in human iPSC neurons |
Amount | £1,400,000 (GBP) |
Organisation | GlaxoSmithKline (GSK) |
Sector | Private |
Country | Global |
Start | 12/2020 |
End | 06/2024 |
Description | Inhibition of alpha-synuclein aggregation and glial activation as a therapeutic strategy for Parkinson's disease |
Amount | £500,000 (GBP) |
Organisation | Bristol-Myers Squibb |
Department | Celgene |
Sector | Private |
Country | United States |
Start | 03/2018 |
End | 03/2021 |
Description | Iona Thomas Wright : Departmental Neuroscience DPhil Studentship Understanding the mechanisms of pathological alpha-synuclein cell-to-cell transfer |
Amount | £75,000 (GBP) |
Organisation | University of Oxford |
Sector | Academic/University |
Country | United Kingdom |
Start | 09/2022 |
End | 09/2026 |
Description | Johanna Hoffman - Understanding organellar calcium signalling in Parkinson's iPSC-dopamine neurons |
Amount | £100,000 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2023 |
End | 09/2026 |
Description | MRC CASE Award with Biogen (Principal Supervisor to William McGuiness. Molecular mechanisms of TFEB in Parkinson's |
Amount | £200,000 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2019 |
End | 09/2022 |
Description | MRC Project Grant MR/V013599: Identifying the regulation of striatal dopamine function by striatal astrocytes in health and parkinsonism (Prof S Cragg & Prof R Wade-Martins) |
Amount | £1,038,078 (GBP) |
Funding ID | MR/V013599 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 02/2021 |
End | 01/2024 |
Description | Mapping the Modulatory Landscape Governing Striatal Dopamine Signaling and Its Dysregulation in Parkinson's Disease. |
Amount | $9,000,000 (USD) |
Organisation | Aligning Sciences Across Parkinson's |
Sector | Charity/Non Profit |
Country | United States |
Start | 11/2021 |
End | 10/2024 |
Description | Maria Claudia Caiazza was awarded an ARUK Thames Valley network Pilot Award |
Amount | £2,500 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2021 |
End | 06/2021 |
Description | Michael J Fox Foundation: In depth phenotypic profiling of PINK1/Parkin stem cell-derived neurons and glia.(Prof Wade-Martins) |
Amount | $600,000 (USD) |
Organisation | Michael J Fox Foundation |
Sector | Charity/Non Profit |
Country | United States |
Start | 08/2021 |
End | 02/2023 |
Description | Michael J Fox Foundation: Validation of FASN as a target for therapeutic development in PD.(Prof Wade-Martins) |
Amount | $200,000 (USD) |
Organisation | Michael J Fox Foundation |
Sector | Charity/Non Profit |
Country | United States |
Start | 03/2021 |
End | 11/2022 |
Description | Mootaz Salman - Organ-on-a-chip human patient stem cell models of the blood-barrier in Parkinson's disease. |
Amount | £115,000 (GBP) |
Organisation | The Leverhulme Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 04/2022 |
End | 04/2025 |
Description | Natalie Connor-Robson Lockey Fund- for travel to World Parkinson's congress |
Amount | £500 (GBP) |
Organisation | Lockey Committee |
Sector | Academic/University |
Country | United Kingdom |
Start | 05/2019 |
Description | Natural Sciences and Engineering Research Council of Canada DPhil Scholarship, and Clarendon Award (Co-supervisors to Kaitlyn Cramb Prof. Richard Wade-Martins & Prof Stephanie Cragg ). In vitro iPSC-derived neuronal circuit models of Parkinson's |
Amount | £117,000 (GBP) |
Organisation | Natural Sciences and Engineering Research Council of Canada (NSERC) |
Sector | Public |
Country | Canada |
Start | 09/2019 |
End | 09/2022 |
Description | Peter Kilfeather awarded funding to study using spatial transcriptomics to look at SNpc and VTA gene expression on wild-type mice compared to SNCA-OVX mice. |
Amount | £22,151 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 05/2021 |
End | 12/2021 |
Description | Post-Doctoral Fellowship (Supervisor to Dr Charmaine Lang): (£210,000; 01/10/19-30/09/21) New molecular targets in Parkinson's disease. |
Amount | £210,000 (GBP) |
Organisation | AstraZeneca |
Sector | Private |
Country | United Kingdom |
Start | 09/2019 |
End | 09/2021 |
Description | Rachel Heon-Roberts, Clarendon Fund & Dept of Physiology, Anatomy, & Genetics. Project title: Establishing a model of a-synuclein and amyloid-ß-induced mitochondrial & lysosomal dysfunction in Alzheimer's disease, PD & Lewy Body dementias |
Amount | £105,000 (GBP) |
Organisation | University of Oxford |
Sector | Academic/University |
Country | United Kingdom |
Start | 09/2021 |
End | 09/2024 |
Description | SRUK winter studentship |
Amount | € 2,400 (EUR) |
Organisation | Society of Spanish Researchers in the United Kingdom |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start |
Description | Stefania Guisanni was successful with an ARUK ECR video awards |
Amount | £320 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 08/2021 |
End | 12/2021 |
Description | Targeting HDAC4 in Parkinson's disease |
Amount | £50,000 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 01/2020 |
End | 02/2021 |
Description | Targeting disease phenotypes in Parkinson's patient iPSC-derived dopamine neurons |
Amount | £650,000 (GBP) |
Organisation | GlaxoSmithKline (GSK) |
Sector | Private |
Country | Global |
Start | 09/2020 |
End | 09/2022 |
Description | Transcriptomic changes in iPSC-derived dopaminergic neurons induced by exposure to alpha-synuclein revealed by single cell RNA-Seq. |
Amount | $200,000 (USD) |
Organisation | Michael J Fox Foundation |
Sector | Charity/Non Profit |
Country | United States |
Start | 08/2021 |
End | 02/2023 |
Description | Transcriptomic changes in iPSC-derived dopaminergic neurons induced by exposure to alpha-synuclein revealed by single cell RNA-Seq. |
Amount | $200,000 (USD) |
Organisation | Michael J Fox Foundation |
Sector | Charity/Non Profit |
Country | United States |
Start | 06/2021 |
End | 02/2023 |
Description | Travel grant for conference for Bryan Ng |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2020 |
End | 03/2020 |
Description | Travel grant for conference for Bryan Ng |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2019 |
End | 03/2019 |
Description | Travel grant for conference for Bryan Ng |
Amount | £300 (GBP) |
Organisation | Alzheimer's Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 03/2020 |
End | 03/2020 |
Description | Understanding vulnerability and resistance in Alzheimer's disease |
Amount | £99,428 (GBP) |
Organisation | Janssen Biotech, Inc. |
Sector | Private |
Country | United States |
Start | 03/2023 |
End | 03/2024 |
Description | Wellcome Integrative Neuroimaging Seed funding - £12,000 . Natalie Connor-Robson |
Amount | £12,000 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start |
Description | Wellcome Trust DPhil Studentship in Neuroscience: Characterisation of a novel GBA-L444P BAC transgenic mouse model of Parkinson's. (Supervisor to Tara Diviney, Co-Supervisor Prof Stephanie Cragg |
Amount | £104,000 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2020 |
End | 09/2023 |
Title | Dopamine neuron microfluidics |
Description | Development of stem cell-derived neuronal culture techniques using microfluidic devices to channel axonal growth. |
Type Of Material | Model of mechanisms or symptoms - in vitro |
Provided To Others? | No |
Impact | Not yet: it is ongoing development |
Title | Osmotic mini-pump implantation |
Description | We have optimised the methodology for delivery of the potential therapeutic CLR01 in vivo usoing osmotic mini-pumps. |
Type Of Material | Model of mechanisms or symptoms - mammalian in vivo |
Provided To Others? | No |
Impact | Pilot data suggest that CLR01 in vivo may reduce a-syn oligomer burden |
Title | PLA in stem cell neurons |
Description | To enable the detection of a-syn oligomers in stem cell-derived dopamine neurons |
Type Of Material | Technology assay or reagent |
Year Produced | 2017 |
Provided To Others? | Yes |
Impact | The detection of a-syn oligomers in stem cell-derived dopamine neurons |
Description | Ajantha Abey in collaboration with Margarida Ruas' lab, University of Oxford |
Organisation | University of Oxford |
Department | Alzheimer's Research UK Oxford Drug Discovery Institute |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | I have provided dopaminergic and cortical neuronal precursors and conducted differentiations into mature neurons with the genetic constructs. I also performed live imaging on the Opera Phenix and fixed and stained cells after growing them for validation. Also provided training on how to differentiate iPSC neurons. |
Collaborator Contribution | Partners provided lentiviral constructs for assaying lysosomal pH, as well as assistance on planning and designing experiments and interpreting preliminary results. |
Impact | n/a |
Start Year | 2023 |
Description | COEN Group on Parkinson's |
Organisation | University of Bordeaux |
Country | France |
Sector | Academic/University |
PI Contribution | We have contributed Parkinson's derived patient-derived stem cells and neurons. We have then used materials and expertise provided by other partners in our patient neuron cultures. |
Collaborator Contribution | The University of the Basque Country has provided expertise on advanced microfluidics cell culture. Bordeaux has provided brain extract from Parkinson's patients and the potential therapic compound CLR01. |
Impact | No outputs yet as collaboration is still new. |
Start Year | 2016 |
Description | COEN Group on Parkinson's |
Organisation | University of the Basque Country |
Country | Spain |
Sector | Academic/University |
PI Contribution | We have contributed Parkinson's derived patient-derived stem cells and neurons. We have then used materials and expertise provided by other partners in our patient neuron cultures. |
Collaborator Contribution | The University of the Basque Country has provided expertise on advanced microfluidics cell culture. Bordeaux has provided brain extract from Parkinson's patients and the potential therapic compound CLR01. |
Impact | No outputs yet as collaboration is still new. |
Start Year | 2016 |
Description | Collaboration with Oxford Drug Discovery Institute (ODDI) |
Organisation | University of Oxford |
Department | Alzheimer's Research UK Oxford Drug Discovery Institute |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | In the collaboration with the Oxford Drug Discovery Institute (ODDI) my team's role is to undertake cell and molecular biology wet lab work to better understand the interaction between HDAC4, NCOR and HDAC3 and how inhibition of HDAC4 will alter that interaction. |
Collaborator Contribution | The role of Oxford Drug Discovery Institute (ODDI) is to test the potency and activity of a range of HDAC4 inhibitors and to consider the drug like properties of new and existing inhibitors. In later stages of the project the ODDI may progress towards high throughput screening to identify novel chemistry and novel HDAC4 inhibitors. |
Impact | Collaboration initiated 2 months ago and work underway. |
Start Year | 2020 |
Description | Dr Ben Vallin with Prof Caleb Webber |
Organisation | UK Dementia Research Institute |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | The project I am working on is a collaborative work with the group of Caleb Webber in Cardiff. This collaboration started on September 2021, is still active, and was funded by the Michael J. Fox Foundation (grant application ID: MJFF-019042; total requested amount: $199,507.80). Our contribution: we designed a cellular model of ?-synuclein propagation composed of dopaminergic neurons derived from healthy control iPSCs co-cultured with dopaminergic neurons derived from Parkinson's disease (PD) iPSCs harbouring a triplication of the ?-synuclein locus. I performed the cell culture, isolated the viable dopaminergic neurons and provided them to the group of Caleb Webber for single cell RNA-sequencing. |
Collaborator Contribution | Caleb Webber's team separated the cell samples we provided into single cells, generated the corresponding cDNA libraries, and performed single cell RNA-sequencing and bioinformatic analysis. |
Impact | n/a |
Start Year | 2021 |
Description | Dr Brent Ryan & Derek Narendra NIH Inherited Movement Disorders Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD |
Organisation | National Institutes of Health (NIH) |
Department | National Institute of Neurological Disorders and Stroke (NINDS) |
Country | United States |
Sector | Public |
PI Contribution | Dr Brent Ryan & Derek Narendra NIH Inherited Movement Disorders Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD. Scope: Collaboration to assess mitophagy in models of PD |
Collaborator Contribution | Dr Brent Ryan & Derek Narendra NIH Inherited Movement Disorders Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD. Scope: Collaboration to assess mitophagy in models of PD Publication: Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ. Trends Biochem Sci. 2020 Dec 12:S0968-0004(20)30278-4. doi: 10.1016/j.tibs.2020.11.007. Online ahead of print. PMID: 33323315 |
Impact | Publication: Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ. Trends Biochem Sci. 2020 Dec 12:S0968-0004(20)30278-4. doi: 10.1016/j.tibs.2020.11.007. Online ahead of print. PMID: 33323315 |
Start Year | 2020 |
Description | Dr Brent Ryan & Dr Elena Britti in collaboration with Dr Katherine England |
Organisation | University of Oxford |
Department | Nuffield Department of Medicine |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Dr Brent Ryan and Dr Elena Britti are working with Dr Katherine England with her ARUK Pilot Award. Title of project: Enhancing the cellular permeability of live cell protein aggregation probes |
Collaborator Contribution | Dr Brent Ryan and Dr Elena Britti are working with Dr Katherine England with her ARUK Pilot Award. Title of project: Enhancing the cellular permeability of live cell protein aggregation probes |
Impact | n/a |
Start Year | 2022 |
Description | Dr Brent Ryan & Evandro Fang University of Oslo, Norway Scope: Assessment of mitophagy modulators in iPSC models of PD |
Organisation | University of Oslo |
Country | Norway |
Sector | Academic/University |
PI Contribution | Dr Brent Ryan collaborating with Evandro Fang University of Oslo, Norway Scope: Assessment of mitophagy modulators in iPSC models of PD Output: Aman Y, Ryan B, Torsetnes SB, Knapskog AB, Watne LO, McEwan WA, Fang EF. Int Rev Neurobiol. 2020;155:169-202. doi: 10.1016/bs.irn.2020.02.008. Epub 2020 Aug 11. PMID: 32854854 |
Collaborator Contribution | Dr Brent Ryan collaborating with Evandro Fang University of Oslo, Norway Scope: Assessment of mitophagy modulators in iPSC models of PD Output: Aman Y, Ryan B, Torsetnes SB, Knapskog AB, Watne LO, McEwan WA, Fang EF. Int Rev Neurobiol. 2020;155:169-202. doi: 10.1016/bs.irn.2020.02.008. Epub 2020 Aug 11. PMID: 32854854 |
Impact | Publication: Aman Y, Ryan B, Torsetnes SB, Knapskog AB, Watne LO, McEwan WA, Fang EF. Int Rev Neurobiol. 2020;155:169-202. doi: 10.1016/bs.irn.2020.02.008. Epub 2020 Aug 11. PMID: 32854854 |
Start Year | 2020 |
Description | Dr Brent Ryan collaboration with Dr Maria Letizia Lo Faro NDSS |
Organisation | University of Oxford |
Department | Nuffield Department of Surgical Sciences Oxford |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Collaboration with Dr Maria Letizia Lo Faro (NDSS) to investigate the role of mitophagy in models of organ transplantation initiated in 2022. Grants pending. |
Collaborator Contribution | Collaboration with Dr Maria Letizia Lo Faro (NDSS) to investigate the role of mitophagy in models of organ transplantation initiated in 2022. Grants pending. |
Impact | Collaboration with Dr Maria Letizia Lo Faro (NDSS) to investigate the role of mitophagy in models of organ transplantation initiated in 2022. Grants pending. |
Start Year | 2022 |
Description | Dr Brent Ryan collaboration with Dr Mark Cookson |
Organisation | National Institute on Aging |
Department | Laboratory of Neurogenetics |
Country | United States |
Sector | Public |
PI Contribution | Collaboration with Dr Mark Cookson (National Institute on Aging, USA) initiated in 2022 to share proteomics datasets from patient iPSC-derived cell types including dopaminergic neurons and microglia. Not governed by formal agreements (grants pending). |
Collaborator Contribution | Collaboration with Dr Mark Cookson (National Institute on Aging, USA) initiated in 2022 to share proteomics datasets from patient iPSC-derived cell types including dopaminergic neurons and microglia. Not governed by formal agreements (grants pending). |
Impact | n/a |
Start Year | 2022 |
Description | Dr Brent Ryan collaboration with Dr Morten Meyer (University of Southern Denmark). |
Organisation | University of Southern Denmark |
Country | Denmark |
Sector | Academic/University |
PI Contribution | Collaboration with Dr Morten Meyer (University of Southern Denmark). Investigation of RhoA signalling in Parkinson's- student Sissel Ida Schmidt is visiting for 6 months. Publication Okarmus et al 2021. |
Collaborator Contribution | Investigation of RhoA signalling in Parkinson's- student Sissel Ida Schmidt is visiting for 6 months. Publication Okarmus et al 2021. |
Impact | Justyna Okarmus, Jesper F. Havelund, Matias Ryding, Sissel I. Schmidt, Helle Bogetofte, Rachel Heon-Roberts, Richard Wade-Martins, Sally A. Cowley, Brent J. Ryan, Nils J. Færgeman, Poul Hyttel, Morten Meyer, Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism, Stem Cell Reports, Volume 16, Issue 6, 2021, Pages 1510-1526, ISSN 2213-6711, https://doi.org/10.1016/j.stemcr.2021.04.022. (https://www.sciencedirect.com/science/article/pii/S2213671121002174) Abstract: Summary PARK2 (parkin) mutations cause early-onset Parkinson's disease (PD). Parkin is an ubiquitin E3 ligase that participates in several cellular functions, including mitochondrial homeostasis. However, the specific metabolomic changes caused by parkin depletion remain unknown. Here, we used isogenic human induced pluripotent stem cells (iPSCs) with and without PARK2 knockout (KO) to investigate the effect of parkin loss of function by comparative metabolomics supplemented with ultrastructural and functional analyses. PARK2 KO neurons displayed increased tricarboxylic acid (TCA) cycle activity, perturbed mitochondrial ultrastructure, ATP depletion, and dysregulation of glycolysis and carnitine metabolism. These perturbations were combined with increased oxidative stress and a decreased anti-oxidative response. Key findings for PARK2 KO cells were confirmed using patient-specific iPSC-derived neurons. Overall, our data describe a unique metabolomic profile associated with parkin dysfunction and show that combining metabolomics with an iPSC-derived dopaminergic neuronal model of PD is a valuable approach to obtain novel insight into the disease pathogenesis. Keywords: Parkinson's disease; parkin; induced pluripotent stem cells; metabolomics; mitochondria; oxidative stress |
Start Year | 2021 |
Description | Dr Brent Ryan collaboration with Prof. Martin Rossel Larsen & Dr Helle Bogetofte (University of Southern Denmark) |
Organisation | University of Southern Denmark |
Country | Denmark |
Sector | Academic/University |
PI Contribution | Collaboration with Prof. Martin Rossel Larsen & Dr Helle Bogetofte (University of Southern Denmark) to perform post-translational proteomics on iPSC-derived neurons generated in Oxford. Not governed by formal agreements (grants pending). |
Collaborator Contribution | Continuing collaboration with Prof. Martin Rossel Larsen & Dr Helle Bogetofte (University of Southern Denmark) to perform post-translational proteomics on iPSC-derived neurons generated in Oxford. Not governed by formal agreements (grants pending). |
Impact | n/a |
Start Year | 2021 |
Description | Dr Mootaz Salman collaboration the University of Glasgow & Aston University |
Organisation | Aston University |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke. Dr Mootaz Salman will collaborate with principal investigator Dr Lorraine Work from the University of Glasgow, together with Professor Roslyn Bill and Dr Stuart Greenhill from Aston University. Over a two-year project, the research team will establish whether the combined targeting of oedema (brain swelling) and neuronal plasticity (the capacity of the nervous system to modify itself) can be used as a new therapeutic framework to treat stroke. This new research objective will expand the translation of a drug candidate that has been described in their groundbreaking research published in the journal Cell in 2020 and a follow-up paper in BBA-Biomembranes in 2021, where Dr Mootaz Salman was both the co-first and corresponding author. In their 2021 paper, the team demonstrated compelling evidence that the drug - the FDA-approved antipsychotic medication known as trifluoperazine (TFP) - has the potential to stop the swelling in the brain that occurs after a stroke or other cerebral injury. |
Collaborator Contribution | n/a |
Impact | n/a |
Start Year | 2023 |
Description | Dr Mootaz Salman collaboration the University of Glasgow & Aston University |
Organisation | University of Glasgow |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke. Dr Mootaz Salman will collaborate with principal investigator Dr Lorraine Work from the University of Glasgow, together with Professor Roslyn Bill and Dr Stuart Greenhill from Aston University. Over a two-year project, the research team will establish whether the combined targeting of oedema (brain swelling) and neuronal plasticity (the capacity of the nervous system to modify itself) can be used as a new therapeutic framework to treat stroke. This new research objective will expand the translation of a drug candidate that has been described in their groundbreaking research published in the journal Cell in 2020 and a follow-up paper in BBA-Biomembranes in 2021, where Dr Mootaz Salman was both the co-first and corresponding author. In their 2021 paper, the team demonstrated compelling evidence that the drug - the FDA-approved antipsychotic medication known as trifluoperazine (TFP) - has the potential to stop the swelling in the brain that occurs after a stroke or other cerebral injury. |
Collaborator Contribution | n/a |
Impact | n/a |
Start Year | 2023 |
Description | Established collaboration with Ira Milosevic, University of Oxford Wellcome Centre for Human Genetics |
Organisation | University of Oxford |
Department | Wellcome Trust Centre for Human Genetics |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | To study synaptic vesicle recycling and STXBP6 biology in our Parkinson's models. Ira will provide the tools and expertise. |
Collaborator Contribution | The collaboration will be to study synaptic vesicle recycling and STXBP6 biology in our Parkinson's models. Ira will provide tools and expertise |
Impact | The collaboration will be to study synaptic vesicle recycling and STXBP6 biology in our Parkinson's models. Ira will provide tools and expertise |
Start Year | 2021 |
Description | International Parkinson's Disease genetic Consortium (IPDGC) |
Organisation | The International Parkinson Disease Genomics Consortium |
Sector | Academic/University |
PI Contribution | New collaboration with the International Parkinson's Disease genetic Consortium (IPDGC); single-cell RNA seq studies, spatial transcriptomics, next generation pathology (i.e. developing deep learning algorithms for PD-related pathologies) |
Collaborator Contribution | New collaboration with the International Parkinson's Disease genetic Consortium (IPDGC); single-cell RNA seq studies, spatial transcriptomics, next generation pathology (i.e. developing deep learning algorithms for PD-related pathologies) |
Impact | New collaboration with the International Parkinson's Disease genetic Consortium (IPDGC); single-cell RNA seq studies, spatial transcriptomics, next generation pathology (i.e. developing deep learning algorithms for PD-related pathologies) |
Start Year | 2019 |
Description | JPND |
Organisation | JPND Research |
Country | Global |
Sector | Academic/University |
PI Contribution | Joint grant funding and projects |
Collaborator Contribution | Working with collaborative members on research activities |
Impact | no |
Start Year | 2016 |
Description | Microfluidics and proximity ligation assay research |
Organisation | Achucarro Basque Center for Neuroscience |
Department | Laboratory of Neurobiology |
Country | Spain |
Sector | Academic/University |
PI Contribution | Nora Bengoa-Vergniory shared her expertise on alpha-synuclein proximity ligation assays |
Collaborator Contribution | Fabio Cavaliere and Paula Ramos shared knowledge of microfludics |
Impact | Ongoing research in both institutes |
Start Year | 2017 |
Description | National Institutes of Health Oxford-Cambridge Scholars Programme (NIH-OxCam) for Stewart Humble |
Organisation | National Institutes of Health (NIH) |
Country | United States |
Sector | Public |
PI Contribution | NIH OxCam programme, a doctoral training programme for medical students to continue their education in biomedical research at either Oxford or Cambridge University in partnership with the National Institutes of Health (NIH) in Washington DC. (PI: Michael Ward, NIH; Co-supervisor: Wade-Martins; 01/10/16-30/09/20) Molecular mechanisms of progranulin in FTD |
Collaborator Contribution | NIH OxCam programme, a doctoral training programme for medical students to continue their education in biomedical research at either Oxford or Cambridge University in partnership with the National Institutes of Health (NIH) in Washington DC. (PI: Michael Ward, NIH; Co-supervisor: Wade-Martins; 01/10/16-30/09/20) Molecular mechanisms of progranulin in FTD |
Impact | NIH OxCam programme, a doctoral training programme for medical students to continue their education in biomedical research at either Oxford or Cambridge University in partnership with the National Institutes of Health (NIH) in Washington DC. (PI: Michael Ward, NIH; Co-supervisor: Wade-Martins; 01/10/16-30/09/20) Molecular mechanisms of progranulin in FTD |
Start Year | 2016 |
Description | Principal Supervisor to Marta Madureira |
Organisation | University of Porto |
Country | Portugal |
Sector | Academic/University |
PI Contribution | As part of the GABBA Doctoral Program, Portugal, Professor Wade-Martins is Principal Supervisor to Marta Madureira; Co-supervisor Dr Jorge Azevedo; 01/11/18-31/12/20) |
Collaborator Contribution | Co supervisors of student |
Impact | Research project title: Regulation of lysosomal physiology by LRRK2 |
Start Year | 2018 |
Description | Quyen Do in collaboration with Cook and Walsh labs from the Department of Engineering at Oxford University |
Organisation | University of Oxford |
Department | Department of Engineering Science |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | We initiated the collaboration with the main objective being to develop an advanced in vitro culture system of human neuronal circuits amenable to wider and more sophisticated experiments. We provided expertise on human neuronal culturing in vitro, neural circuit and biological knowledge which is critical to design and empirically assess the utility of their platform to attain our culturing objective. |
Collaborator Contribution | They provided technical expertise and instrumentation to fabricate useful fluid-walled microfluidic platforms which was previously developed within their lab for the purpose of culturing human neuronal circuits in vitro. |
Impact | Together, we have successfully established a paradigm to culture human neuronal microcircuits on fluid-walled microfluidics which is adaptable for multiple experimental purposes. Manuscript for this project is in preparation. |
Start Year | 2022 |
Description | Rachel Heon Roberts in collaboration with the Kakura laboratory, University of Oxford |
Organisation | University of Oxford |
Department | Department of Chemistry |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I am providing expertise regarding alpha-synuclein aggregation, and we are also providing some of the equipment (PheraStar, bacterial shaker). |
Collaborator Contribution | The Kukura lab is also providing some of the equipment and expertise, surrounding the mass photometer microscope, as well as performing almost all the manipulations (alpha-synuclein aggregation and Thioflavin T assay, mass photometry readings and data analysis). |
Impact | This collaboration was started in 2022 and has not yet produced any publications. |
Start Year | 2022 |
Description | Rachel Heon Roberts in collaboration with the Magill laboratory, University of Oxford |
Organisation | Medical Research Council (MRC) |
Department | MRC Brain Network Dynamics Unit at the University of Oxford (BNDU) |
Country | United Kingdom |
Sector | Public |
PI Contribution | I am growing the cell lines, providing samples for optimisation of the technique, providing the reagents for cell culture and immunocytochemistry, as well as performing most of the manipulations. |
Collaborator Contribution | The Magill lab is assisting with their expertise, providing the equipment needed (ex ultramicrotome, electron microscope), and the reagents needed for electron microscopy. |
Impact | We have not yet published, but the abstracts I have sent to conferences this year feature some of the results obtained from this collaboration. |
Start Year | 2021 |
Description | T-cell activation in Parkinson's |
Organisation | University of Oxford |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Analysis of response of Parkinson's patient PBMCs to stimulation by alpha-synuclein |
Collaborator Contribution | Advice on growth and culture of PBMC and how to measure T-cell activation by ELISpot |
Impact | Collaboration is multi-disciplinary between molecular genetics (Wade-Martins lab) and our partner immunology lab. No outcomes yet. |
Start Year | 2019 |
Description | WIN MRI group for imaging mice Natalie Connor-Robson |
Organisation | Wellcome Trust |
Department | Wellcome Trust Cente for Neuroimaging |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | WIN MRI group for imaging mice Natalie Connor-Robson |
Collaborator Contribution | WIN MRI group for imaging mice Natalie Connor-Robson |
Impact | WIN MRI group for imaging mice Natalie Connor-Robson |
Start Year | 2019 |
Description | ARUK Dementia Open morning - postponed 3 days before event took place due to COVID-19 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | The 2020 Dementia Awareness Day was held at the John Radcliffe Hospital in Oxford in March 2020. The Thames Valley ARUK Network Centre organise this event to discuss current dementia research taking place within the network centre, which includes the University of Oxford, Oxford Brookes University and University of Reading. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.oxdare.ox.ac.uk/arukox-public |
Description | ARUK Oxford Network Research Day presentation July 2019 - Bryan Ng |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | In July 2019, Bryan Ng attended the ARUK Oxford Network Research Day and gave a presentation |
Year(s) Of Engagement Activity | 2019 |
Description | ARUK Thames Valley Network Dementia Research day |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | On 1st July 2022, The ARUK Thames Valley network hosted a Dementia Research day. The host was Becky Carlyle, ARUK Thames Valley Network coordinator. The day include presentations by Becky Carlyle, Peter Kilfeather, Hugo Fernandes, and Maria Claudia Caiazza from the Wade-Martins lab. |
Year(s) Of Engagement Activity | 2022 |
Description | ARUK Thames Valley Network Translational Research in Dementia - Collaboration building event |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On Friday 11th November 2022, the ARUK Thames Valley Network hosted a Translational Research in Dementia - Collaboration building event at Oxofrd Brookes University. The event was hosted by Becky Carlyle ARUK Thames Valley Network coordinator and Dr Patrick Esser, ARUK Thames Valley Network Committee member. It was attended by researchers from Oxford Brookes University, University of Oxford and the University of Reading. |
Year(s) Of Engagement Activity | 2022 |
Description | ARUK conference poster presentation in March 2020 - Bryan Ng - EVENT CANCELLED DUE TO CORONAVIRUS |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | ARUK conference poster presentation in March 2020 - Bryan Ng |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.alzheimersresearchuk.org/for-researchers/research-conference-2020/abstracts/ |
Description | ARUK/BRC Oxford Dementia Research Day |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | a day of talks celebrating the exciting research in the region including updates on some of the exciting big dementia research initiatives such as the ARUK Oxford Drug Discovery Institute, Dementia Platform UK, the NIHR Oxford Health Biomedical Research Centre and the Oxford Momentum Award. Accredited for 5 CPD credits. |
Year(s) Of Engagement Activity | 2017 |
URL | https://www.dpag.ox.ac.uk/research/wade-martins-group/oxford-aruk-network-centre/research-day-2015 |
Description | Ajantha Abey presented a poster at the at DPUK Translation conference 23. title: 'Investigating Selective Neuronal Vulnerability in Alzheimer's and Parkinson's Disease Using Induced Pluripotent Stem Cells'. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | In March 2023, Ajantha Abey presented a poster at the at DPUK Translation conference 23 |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.dementiasplatform.uk/research-hub/translation-2023 |
Description | Aligning Science Across Parkinson's (ASAP) Consortium Meeting on 1st and 2nd September 2022 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 1st and 2nd September 2022, the first Aligning Science Across Parkinson's (ASAP) Consortium Meeting was held at the Department of Pharmacology, University of Oxford. The two day event included talks and posters from the Wade-Martins lab, the Cragg lab, the Magill lab, and from our collaborators Mark Howe (Boston) and Dinos Meletis (Karolinska). |
Year(s) Of Engagement Activity | 2022 |
URL | https://twitter.com/ASAP_Research/status/1585270635118428163 |
Description | Alzheimer's Research UK Thames Valley Network dementia public evening event |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | On 12 October 2022, Becky Carlyle gave a public talk on behalf of the Alzheimer's Research UK Thames Valley Network at Keble College. The talk focussed on the accusations of scientific fraud in Alzheimer's Disease research that were reported in the press in July, and the implications of these accusations for patients, researchers, and the race to cure Alzheimer's Disease. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.eventbrite.co.uk/e/alzheimers-research-uk-thames-valley-network-dementia-public-evening-... |
Description | Article featured on the DPUK website (Can a type of supportive brain cell rescue neurons damaged by Parkinson's disease? - DPUK (dementiasplatform.uk)) |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | In October 2021, an article about Naroa Ibarra Aizpurua's research was featured on the DPUK website, titled, 'Can a type of supportive brain cell rescue neurons damaged by Parkinson's disease?' |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dementiasplatform.uk/research-hub/stem-cell-network/can-a-type-of-supportive-brain-cell-... |
Description | Attended the ARUK Oxford Network Outreach Day in March 2019 |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | The 2019 Dementia Awareness Day was held at the John Radcliffe Hospital in Oxford in March 2019. The Oxford ARUK Network Centre organise this event to discuss current dementia research taking place within the network centre, which includes the University of Oxford, Oxford Brookes University and University of Reading. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.oxdare.ox.ac.uk/openday2019 |
Description | Biochemistry Society LRRK2 Meeting, Lille, France |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 30 June 2022, Professor Wade-Martins gave a talk titled, 'The role of LRRK2 in the autophagic/lysosomal pathway' at the Biochemistry Society LRRK2 Meeting, Lille, France |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.eventsforce.net/biochemsoc/frontend/reg/tAgendaWebsite.csp?pageID=44265&daySelector=3&ev... |
Description | Blog by Bryan Ng on DPUK website |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | A Blog was written and posted on the DPUK website on 21 April 2020 |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.dementiasplatform.uk/news-and-blogs/blog/pioneering-stem-cell-research-dementia |
Description | Bryan Ng attended the Alzheimer's Association International Conference and presented a poster in July 2019 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | In July 2019, Bryan Ng attended the Alzheimer's Association International Conference and presented a poster. |
Year(s) Of Engagement Activity | 2019 |
URL | https://c-path.org/poster-presentation-at-the-2019-alzheimers-association-international-conference-j... |
Description | Caution when looking at cell recycling in Parkinson's |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Supporters |
Results and Impact | Media press release by Parkinson's UK highlighting that researchers at the Oxford Parkinson's Disease Centre have shown that cell recycling in Parkinson's may play a more complex role than previously thought. These new results have been published in the journal of Cell Reports. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.parkinsons.org.uk/news/caution-when-looking-cell-recycling-parkinsons |
Description | Celebrating international day of women and girls in science. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In February 2022, we celebrated international day of women and girls in science by sharing a video featuring three of our researchers Becky Carlyle, Charmaine Lang, and Gabriela Vilema Enriquez |
Year(s) Of Engagement Activity | 2022 |
URL | http://youtu.be/U0yGdxZ7k2A |
Description | Collaborative visit to Oxford by University of Sheffield on Tuesday 27 September |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Researchers from the University of Sheffield visited Oxford in September to discuss new data from our Michael J Fox funded Parkinson's project |
Year(s) Of Engagement Activity | 2022 |
URL | https://twitter.com/HeatherMortiboy/status/1575834919724789763 |
Description | Department's Science in the Park event |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Researchers joined in the Department's Science in the Park event where children joined Scientists from the Department of Physiology, Anatomy, and Genetics in University Parks where they learnt more about how bodies work. |
Year(s) Of Engagement Activity | 2022,2023 |
URL | https://www.dpag.ox.ac.uk/news/dpag-and-biochemistry-inspire-local-children-with-second-science-in-t... |
Description | Downing Street |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | Inivitation to attend reception at 10, Downing Street |
Year(s) Of Engagement Activity | 2017 |
Description | Dr Dayne Beccano-Kelly became an international science ambassador for the World Parkinson's Congress 2022. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Dr Dayne Beccano-Kelly became an international science ambassador for the World Parkinson's Congress 2022.Their focus leading up to the Congress is to help drive up participation of scientists to attend the WPC. |
Year(s) Of Engagement Activity | 2020 |
URL | https://wpc2022.org/page/2022ScienceAmb |
Description | Dr Dayne Beccano-Kelly established the Aspiring Black Physiologists award with the Physiological Society |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Schools |
Results and Impact | Dr Dayne Beccano-Kelly, along the Physiological Society established the Aspiring Black Physiologists award to address the disparity of black scientist in STEM research by encouraging black students at young ages to engage with and consider science research as a viable career path. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.physoc.org/careers/supporting-your-next-career-move/aspiring-black-physiologists/. |
Description | Dr Dayne Beccano-Kelly gave a talk at the Neurodegeneration Challenge Network (NDCN) online forum funded by the Chan Zuckerberg initiative (CZI) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 10th September 2020, Dr Dayne Beccano-Kelly gave a talk at the Neurodegeneration Challenge Network (NDCN) online forum funded by the Chan Zuckerberg initiative (CZI) |
Year(s) Of Engagement Activity | 2020 |
Description | Dr Dayne Beccano-Kelly gave a talk at the SelectScience Virtual Neuroscience Summit 2020 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Dr Dayne Beccano-Kelly gave a talk at the SelectScience Virtual Neuroscience Summit 2020. The presentation tiles was 'Once upon a time at the synapse: A tale of early dysfunction in Parkinson's Disease' The presentation was recorded and featured on the Scientists' Channel: https://thescientistschannel.com/dayne-beccano-kelly |
Year(s) Of Engagement Activity | 2020 |
URL | https://neurosciencesummit2020.vfairs.com/en/#home |
Description | Dr Dayne Beccano-Kelly gave a talk on "Diversity in Teaching" to the Physiological Society as part of their webinar series |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Dr Dayne Beccano-Kelly gave a talk on "Diversity in Teaching" by the Physiological Society He spoke about his project to make the study of physiology more appealing to BAME populations by using a competition asking participants to identify culturally appropriate role models. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.physoc.org/events/diversity-in-teaching/ |
Description | Dr Dayne Beccano-Kelly was interviewed by Parkinson's UK about Parkinson's Research and Diversity |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | In December 2020, Dr Dayne Beccano-Kelly gave an interview to Parkinson's UK about Research and Diversity |
Year(s) Of Engagement Activity | 2020 |
URL | https://medium.com/parkinsons-uk/a-researchers-view-parkinson-s-research-and-diversity-ecbee4720359 |
Description | Dr Dayne Beccano-Kelly was recognised for his contribution to science research by University of Oxford during Black History Month: |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | During Black History Month, the University highlighted the power of excellence and academic achievement, past and present, and how the contributions of Black people have contributed to the calibre of the University's reputation. Dr Dayne Beccano-Kelly was recognised for his contribution to science research by University of Oxford during Black History Month. |
Year(s) Of Engagement Activity | 2020 |
URL | https://medium.com/oxford-university/the-oxford-bhm-100-7af54c5b2764 |
Description | Dr Mootaz Salman gave a talk at the Department of Stem Cell Biology- Innovative Medical Centre in Vilnius/ Lithuania. Presentation title: 3D organ-on-a-chip models to investigate CNS disorders. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 27 January 2022, Dr Mootaz Salman gave a talk at the Department of Stem Cell Biology- Innovative Medical Centre in Vilnius/ Lithuania. Presentation title: 3D organ-on-a-chip models to investigate CNS disorders. |
Year(s) Of Engagement Activity | 2022 |
URL | http://www.imcentras.lt/en/ |
Description | Dr Mootaz Salman gave an in person talk as part of the DPAG Head of Department: Fellows in Pair Lecture seminar series |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 4 February, Dr Mootaz Salman gave a talk as part of the DPAG Head of Department: Fellows in Pair Lecture seminar series. His presentation title was "Defining mechanisms of blood-brain barrier dysfunction in dementia using advanced organ-on-a-chip models" |
Year(s) Of Engagement Activity | 2022 |
URL | https://talks.ox.ac.uk/talks/id/bbab1b2e-6e4b-4f57-a607-4b0d58d5f419/ |
Description | Dr Natalie Connor-Robson gave an online talk to the Parkinson's UK Henley Branch |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | On 24th February Dr Natalie Connor-Robson gave an outreach talk to the Henley Parkinson's UK Branch |
Year(s) Of Engagement Activity | 2021 |
Description | Dr Nora Bengoa-Vergniory & Dr Sophie Morgan gave an online presentation for the ARUK Thames Valley Network |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Due to the COVID-19 pandemic, we were unable to hold the 2020 Alzheimer's Research UK Thames Valley Network Dementia Open Morning. Over the summer presenters within the network centre who were due to talk at the March public event to give their talks online. The short talks from scientists were recorded and include a range of topics in dementia. They are available on YouTube. Sophie Morgan presentation title was 'Protein aggregation and Parkinson's disease' Nora Bengoa-Vergniory presentation title was 'Microscopic tweezers, a new avenue for treatment of neurodegenerative diseases'. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.youtube.com/playlist?list=PLPN7gkQCguDT-JdBjLXyTxJ_i7wCXhjYO |
Description | Dr Pavandeep Rai was a judge in an Beyond Boundaries 2020 competition |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Dr Pavandeep Rai was a judge in an Beyond Boundaries 2020 competition; an outreach event to schools in Oxfordshire. The University of Oxford invited schools to participate in an art competition for Oxfordshire state school students to create art inspired by research from Black, Asian and Minority Ethnic scientists. Students were asked to choose one of six scientists to create an artistic response to their research (e.g. painting, drawing, sculpture, animation, other artistic media) along with a short statement explaining the artwork. Due to COVID-19, there was a delay to announcing the winners. The winners are to be called in January 2021 and an exhibition of their work will take place online now. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.oxfordsparks.ox.ac.uk/content/beyond-boundaries-2020 |
Description | Dr. Nora Bengoa-Vergniory gave a Poster tour presentation at the World Parkinson's Congress, Kyoto Japan. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Dr. Nora Bengoa-Vergniory gave a Poster tour presentation at the World Parkinson's Congress, Kyoto Japan. Subject: CLR01 protects dopaminergic neurons in vitro and in vivo in mouse and human models |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.worldpdcoalition.org/page/PastCongresses |
Description | Dr. Nora Bengoa-Vergniory gave a oral presentation at the Neuroscience symposium, Oxford UK (2019). |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Dr. Nora Bengoa-Vergniory gave a oral presentation at the Neuroscience symposium, Oxford UK (2019). |
Year(s) Of Engagement Activity | 2019 |
Description | Dr. Nora Bengoa-Vergniory gave an oral presentation at the Parkinson's Disease Gordon Research Conference Seminar, Maine USA |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Dr. Nora Bengoa-Vergniory gave an oral presentation at the Parkinson's Disease Gordon Research Conference Seminar, Maine USA June 23 - 28, 2019 Subject: CLR01 protects dopaminergic neurons in vitro and in vivo in mouse and human models |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.grc.org/parkinson-s-disease-conference/2019/ |
Description | Fundraising activity during lockdown for Parkinson's UK |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | During the Covid pandemic lockdown, members of the Wade-Martins Group from the Oxford Parkinson's Disease Centre fundraised for Parkinson's UK with a variety of imaginative challenges for the national 2.6 challenge campaign. £1,197 was raised for the charity. |
Year(s) Of Engagement Activity | 2020 |
URL | http://www.dpag.ox.ac.uk/news/opdc-researchers-hit-target-for-parkinsons-uk-with-2-6-challenge |
Description | Gordon Research Conference |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Nora Bengoa-Vergniory "Mass-spectrometry approach highlights REST as a potential neuroprotective target for Parkinson's disease in an alpha synuclein overexpressing BAC-transgenic mouse model" Oral presentation Posters: Nora Bengoa-Vergniory, Dayne Beccano-Kelly, Natalie Connor-Robson, Rebecca Wallings |
Year(s) Of Engagement Activity | 2017 |
URL | https://www.grc.org/parkinson-s-disease-conference/2017/ |
Description | In March 2023, Kalina Naidoo presented a Blitz Poster (1 minute flash talk + poster) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | In March 2023, Kalina Naidoo presented a Blitz Poster (1 minute flash talk + poster) titled, 'An investigation of Gcase modulators in iPSC derived dopaminergic neurons' at the first in-person Parkinson's disease Early Career Researcher (ECR) meeting at the Core Technology Facility, University of Manchester. |
Year(s) Of Engagement Activity | 2023 |
Description | Inaugural Fellowship to Charmaine Lang paves the way to improved human models for Parkinson's drug discovery |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Dr Charmaine Lang has been awarded the first jointly funded Senior Research Fellowship from Parkinson's UK and Rosetrees Trust. With this award, Dr Lang will develop complex new induced pluripotent stem cell (iPSC) models that target the interaction between dopamine neurons and astrocytes in the brain and how these fail in the context of Parkinson's. |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.dpag.ox.ac.uk/news/inaugural-fellowship-charmaine-lang-improved-human-models-parkinsons-... |
Description | Institute of Genetics and Biophysics, Naples, Italy |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | In March 2022, Professor Richard Wade-Martins gave a talk at the Institute of Genetics and Biophysics, Naples, Italy |
Year(s) Of Engagement Activity | 2022 |
Description | International alpha-synuclein meeting, Leuven, Belgium |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | In April 2022, Professor Richard Wade-Martins was the opening speaker at the International alpha-synuclein meeting in Leuven, Belgium |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.kuleuven.be/brain-institute/events-and-outreach/synuclein-2022-meeting |
Description | Invited to talk at the ARUK Dementia Research Day - Dr. Nora Bengoa-Vergniory |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | On 31July 2019, was invited to talk at the ARUK Dementia Research Day. Subject: CLR01 protects dopaminergic neurons in vitro and in vivo in mouse and human models |
Year(s) Of Engagement Activity | 2019 |
Description | Monthly attendance a the Parkinson's UK Oxford branch meetings |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | During 2022, members of the Wade-Martins lab attend in person the monthly Parkinson's UK Oxford Branch meetings to meet with PWP. |
Year(s) Of Engagement Activity | 2022 |
URL | https://oxfordparkinsons.org.uk/ |
Description | Mootaz Salman appointed Departmental Research Lecturer |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In December 2021, Dr Mootaz Salman was conferred the title of Departmental Research Lecturer in recognition of his contribution to his research group and the teaching and research mission of DPAG. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dpag.ox.ac.uk/news/mootaz-salman-appointed-departmental-research-lecturer |
Description | Neurogune talks, Bilbao Spain |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | "Alpha-synuclein overexpressing mice and protection of neurons from synuclein toxicity by molecular tweezers" Oral presentation Nora Bengoa-Vergniory |
Year(s) Of Engagement Activity | 2017 |
Description | New item: New study shows clinical symptoms for Alzheimer's can be predicted in preclinical models |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer's brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.dpag.ox.ac.uk/news/new-study-shows-clinical-outcomes-for-alzheimers-can-be-predicted-in-... |
Description | News Article featuring the winners of the DPAG Student Poster Day 2021 |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | In November 2021, there was a news article featuring the winners of the DPAG Student Poster Day 2021. One of the runners up was Tara Diviney from the Wade-Martins lab. Tara Diviney, supervised by Dr Natalie Connor-Robson, Professor Stephanie Cragg and Professor Richard Wade-Martins, with "Characterisation of a novel GBA-L444P BAC transgenic mouse model of Parkinson's disease". |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dpag.ox.ac.uk/news/winners-of-the-dpag-student-poster-day-2021-announced |
Description | News Item: Charmaine Lang appointed Departmental Research Lecturer |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Dr Charmaine Lang has been conferred the title of Departmental Research Lecturer in recognition of her contribution to her research group and the teaching and research mission of DPAG. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.dpag.ox.ac.uk/news/charmaine-lang-appointed-departmental-research-lecturer |
Description | News article as researchers from the OPDC and the Wade-Martins Group move |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In June 2021, researchers from the OPDC and the Wade-Martins Group recently moved to brand new laboratory facilities at the Kavli Institute for NanoScience Discovery. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dpag.ox.ac.uk/opdc/news/latest/new-laboratory-facilities-for-opdc-researchers |
Description | News article to celebrate building of new laboratory space for OPDC Researchers |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | A news article celebrate a major building in the centre of Oxford has been constructed to create a new research centre bringing together cellular neuroscience and physical sciences. Members of the OPDC will move into the new building. Known as the new Kavli Institute for NanoScience Discovery (Kavli INSD), the building will uniquely combine structural biology with world-leading biochemistry, pathology, chemistry, physics, physiology and engineering. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dpag.ox.ac.uk/opdc/news/latest/new-laboratory-space-for-opdc-researchers |
Description | News article to celebrate research success in World Parkinson's Month April 2020 |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | In April 2020, a news article was published to celebrate research success in World Parkinson's Month |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.dementiasplatform.uk/news-and-blogs/news/world-parkinsons-month-frontier |
Description | News article to promote the Wade-Martins Group achieving Bronze award for sustainable practices |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In October 2021, the Wade-Martins Group achieved a Laboratory Efficiency Assessment Framework (LEAF) Bronze award in recognition of its sustainable practices. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dpag.ox.ac.uk/news/wade-martins-group-achieves-bronze-award-for-sustainable-practices |
Description | News item: Fellowship awarded to Mootaz Salman could pave the way for early intervention in Parkinson's |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Dr Mootaz Salman has been awarded a Leverhulme Trust Early Career Fellowship - a highly prestigious, fiercely competitive research award with just 145 awards available nationally this year across all disciplines. These fellowships enable early career academics to undertake a significant piece of publishable work. Dr Salman is now pursuing a 3-year research project entitled "Targeting mechanisms of blood-brain barrier dysfunction in Parkinson's using humanized 3D brain-on-a-chip models", on which he will work independently within DPAG in close collaboration with the Wade-Martins Group. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.dpag.ox.ac.uk/news/fellowship-awarded-to-mootaz-salman-could-pave-the-way-for-early-inte... |
Description | News item: Oxford Parkinson's Disease Centre awarded £3.8 million to reveal the role of calcium in Parkinson's |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Researchers at the Oxford Parkinson's Disease Centre led by Professor Richard Wade-Martins with Professor Stephanie Cragg and Professor Peter Magill, have been awarded a £3.8 million Wellcome Trust Collaborative Award in Science to study the critical role of calcium in the biology of dopamine neurons. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.dpag.ox.ac.uk/news/opdc-awarded-3-8-million-to-reveal-the-role-of-calcium-in-parkinsons |
Description | News item: The Wade-Martins Group achieved a Laboratory Efficiency Assessment Framework (LEAF) Silver award in recognition of its sustainable practices. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | The Wade-Martins Group has achieved a Laboratory Efficiency Assessment Framework (LEAF) Silver award in recognition of its sustainable practices. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.dpag.ox.ac.uk/news/wade-martins-group-attain-silver-sustainability-award |
Description | News of a major new $9 million project funded by the Aligning Science Across Parkinson's (ASAP) initiative |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In October 2021, it was announced that a major new $9 million project funded by the Aligning Science Across Parkinson's (ASAP) initiative will map the original circuits vulnerable to Parkinson's on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dpag.ox.ac.uk/news/mapping-uncharted-networks-in-the-progression-of-parkinsons |
Description | News story about OPDC's Natalie Connor-Robson engagement work on widening access to STEM skills with In2scienceUK |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Schools |
Results and Impact | OPDC Career Development Fellow Natalie Connor-Robson shares STEM career advice with students taking part in the In2scienceUK programme. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/opdc-s-natalie-connor-robson-widens-access-to-stem-skills-with-in2scienceu... |
Description | News story about a collaborative study led by the OPDC's Dr Nora Bengoa-Vergniory |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Media (as a channel to the public) |
Results and Impact | News story about a collaborative study led by the OPDC's Dr Nora Bengoa-Vergniory that has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson's. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/tiny-brain-tweezers-could-hold-the-key-to-treat-parkinson-s |
Description | News story and video featuring the Wade-Martins lab to mark World Parkinson's Day |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | News story to mark World Parkinson's Day, featuring a video with an inside look into the Wade-Martins Laboratory. The Wade-Martins Group conducts critical research into several neurodegenerative diseases, and makes up part of the OPDC with its work into Parkinson's, with the aim to understand the molecular mechanisms of these disorders and help develop new treatments. This video is narrated by Professor Richard Wade-Martins, with contributions from Charmaine Lang, Dayne Beccano-Kelly, Peter Kilfeather, Phillippa Carling, Gabriela Vilema Enriquez and former members of the team, Gabriele Corda, Rebecca Wallings and Marta Cherubini. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.opdc.ox.ac.uk/inside-the-wade-martins-lab |
Description | News story and video highlighting an OPDC study that has uncovered a new way to target and treat the leading genetic contributor to Parkinson's |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Supporters |
Results and Impact | News story featuring a research paper that has identified how the dysfunction of a key protein, LRRK2, causes the neurons affected in Parkinson's to lose their ability to effectively clear out cell components that have been damaged. This discovery has enabled the team to find a new way to target and correct this issue, paving the way for a potential new clinical treatment. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.opdc.ox.ac.uk/opdc-study-uncovers-a-new-way-to-target-and-treat-the-leading-genetic-cont... |
Description | News story featuring a new study on neurons grown from skin samples reveals key molecular changes in people with Parkinson's |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Supporters |
Results and Impact | News story highlighting a new research paper in Human Molecular Genetics: Cellular a-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.opdc.ox.ac.uk/new-opdc-study-on-neurons-grown-from-skin-samples-reveals-key-molecular-ch... |
Description | News story highlighting Dayne Beccano-Kelly, who shares his experience of being a black professional in academia & the wider story of race in research |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Dayne Beccano-Kelly, an electrophysiologist and Career Development Fellow in the Department of Physiology, Anatomy and Genetics, and part of the Oxford Parkinson's Disease Centre (OPDC) spoke to Parkinson's Life about his experience as a black professional working in Parkinson's research. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/opdc-researcher-shares-his-experience-of-being-a-black-professional-in-aca... |
Description | News story highlighting a new paper to report genome-wide transcriptomic RNA-Seq profiling of stem cell-derived astrocytes from people with Parkinson's & healthy controls. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | The news items highlighted a new research paper that was published to report genome-wide transcriptomic RNA-Seq profiling of stem cell-derived astrocytes from people with Parkinson's & healthy controls. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.opdc.ox.ac.uk/new-opdc-research-into-the-role-of-astrocytes-in-parkinson-s-progression |
Description | News story highlighting a new study which has shown that the key protein RE1 Silencing Transcription Factor (REST) regulates the health of those neurons critically affected in Parkinson's Disease. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | A study led by University of Oxford researchers, Dr Brent Ryan and Dr Nora Bengoa-Vergniory has shown that the key protein RE1 Silencing Transcription Factor (REST) regulates the health of those neurons critically affected in Parkinson's Disease. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.opdc.ox.ac.uk/dopamine-neurons-need-a-rest-in-parkinson-s-disease |
Description | News story highlighting a study that a novel assay termed the tau-proximity ligation assay is able to recognise Alzheimer's disease before current detection methods. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | A study led by the Oxford Parkinson's Disease Centre's (OPDC) Dr Nora Bengoa-Vergniory has shown that a novel assay termed the tau-proximity ligation assay is able to recognise Alzheimer's disease before current detection methods. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.opdc.ox.ac.uk/tau-proximity-ligation-assay-reveals-extensive-previously-undetected-patho... |
Description | News story promoting that Milena Cioroch is awarded Apprentice of the Month for March 2020 |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Milena Cioroch, Research Assistant in the Wade-Martins Lab at the Oxford Parkinson's Disease Centre, was awarded Apprentice of the Month for March 2020 by her training provider Abingdon and Witney College. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/milena-cioroch-is-awarded-apprentice-of-the-month-for-march-2020 |
Description | News story promoting that a new study finds mutations in the gene LRRK2 affect normal cell function |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Supporters |
Results and Impact | A new story featured on our website about a new study from OPDC Career Development Fellow Natalie Connor-Robson who has investigated how mutations in the gene LRRK2, which are known to cause Parkinson's, effect normal cell function. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.opdc.ox.ac.uk/opdc-study-finds-mutations-in-the-gene-lrrk2-affect-normal-cell-function |
Description | News story to highlight OPDC Career Development Fellow Dr Dayne Beccano-Kelly has been selected by The World Parkinson Coalition (WPC) to be one of eight Science Ambassadors leading up to the 6th World Parkinson Congress |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | PDC Career Development Fellow Dr Dayne Beccano-Kelly has been selected by The World Parkinson Coalition (WPC) to be one of eight Science Ambassadors leading up to the 6th World Parkinson Congress in June 2022. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/opdc-s-dayne-beccano-kelly-appointed-world-parkinson-coalition-science-amb... |
Description | News story to highlight OPDC Researchers participating in fundraising for Parkinson's UK |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | On Sunday 26 April, members of the Wade-Martins Group from the Oxford Parkinson's Disease Centre threw themselves into a variety of imaginative challenges for the national 2.6 challenge campaign to raise vital funds for Parkinson's UK. The challenge required participants to dream up an activity based around the numbers 2.6 or 26 that suits their skills and complete it on Sunday 26 April - when the 40th London Marathon would have taken place. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.dpag.ox.ac.uk/news/opdc-researchers-hit-target-for-parkinsons-uk-with-2-6-challenge |
Description | News story to highlight a collaborative Oxford Parkinson's Disease Centre and Cardiff University study on the cellular origins of Parkinson's could be key to developing new treatments. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | New paper highlighting the results from a collaborative Oxford Parkinson's Disease Centre and Cardiff University study on the cellular origins of Parkinson's could be key to developing new treatments. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/genetic-study-points-to-cells-responsible-for-parkinson-s |
Description | Nora Bengoa-Vergniory article on Celgene Fellowship |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Postgraduate students |
Results and Impact | Interviwe with Dr Nora Bengoa-Vergniory on her experience as a Celgene Fellow for the Oxford University Medical Sciences division website |
Year(s) Of Engagement Activity | 2018 |
URL | https://www.medsci.ox.ac.uk/research/internal/funding-directory/oxford-celgene-fellowship/oxford-cel... |
Description | Numerous social media posts to welcome new lab members |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Over the year, we have sent numerous social media post welcoming new lab members to the research team, and linking to their profiles on our website |
Year(s) Of Engagement Activity | 2021 |
Description | OPDC Open Day 2016 |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Study participants or study members |
Results and Impact | OPDC Open Day 2016 250 OPDC study Participants and Partners registered for event. Day of talks from Michele Hu, Fahd Baig, Claudio Ruffmann, Tom Barber and Richard Wade-Martins. Discussion of what participants would like from study. Talks filmed and podcasts added to website |
Year(s) Of Engagement Activity | 2016 |
URL | http://www.opdc.ox.ac.uk/openday2016 |
Description | OPDC Research Day |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | The OPDC Research Day is a one-day event with research talks from world leading Parkinson's researchers on topics including clinical studies, imaging, genetics, proteomics, neuronal cells and animal models. The 2017 OPDC Research Day was held in the Medical Sciences Teaching Centre, Oxford. There was a full day of talks and poster sessions on Parkinson's research. This one-day event included research talks by national and international keynote speakers and Oxford researchers on a range of Parkinson's work including clinical studies, imaging, genetics, proteomics, neuronal cell culture and animal models. |
Year(s) Of Engagement Activity | 2017 |
URL | http://www.opdc.ox.ac.uk/research2017 |
Description | OPDC Seminar 11 February 2022 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 11 February 2022, Louis-Eric Trudeau gave an OPDC Seminar talk, titled, 'Making sense of the exuberant axonal connectivity of dopamine neurones'. |
Year(s) Of Engagement Activity | 2022 |
URL | https://talks.ox.ac.uk/talks/id/df0f906f-bf3d-41ca-b7fb-3026912ce1bf/ |
Description | OPDC Seminar 20 January 2020 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On behalf of Professor Richard Wade-Martins, Dr Matthew LaVoie gave a talk on 'Proteostasis and Mitochondrial Pathways in the Pathogenesis and Treatment of Parkinson's Disease on Monday 20 January 2020 |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | OPDC Seminar 20 January 2022 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 20 January 2022, Pietro De Camilli gave an OPDC Seminar talk, titled, 'Intracellular Membrane Lipid Dynamics and Neurodegenerative Diseases'. |
Year(s) Of Engagement Activity | 2021,2022 |
URL | https://talks.ox.ac.uk/talks/id/27284d4a-7121-4d63-9c39-fe40f59dd518/ |
Description | OPDC Seminar 22 November 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 22 November 2021, Dr Michael Henderson gave an OPDC seminar talk titled, 'Modulators of pathology progression in neurodegenerative disease'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/c26bb54d-93e4-406a-80c1-43bcbf11b31e/ |
Description | OPDC Seminar 26 January 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | On 26th January 2021, Dr Wilma van de Berg gave an OPDC emianr talk titled, ' Tales from the human brain: a multi scale approach to elucidate pathogenic mechanisms involved in Parkinson's'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.opdc.ox.ac.uk/seminars-events |
Description | OPDC Seminar 3 February 2020 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On behalf of Professor Richard Wade-Martins, Dr Michael Ward, National Institute of Neurological Disorders and Stroke, gave a talk on 'Combining iPSCs and 'omics to identify molecular convergence in neurodegenerative disorders' on Monday 3 February 2020. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | OPDC Seminar 8 February 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | On *th February 2021, Emmanouil Metzakopian gave an OPDC Seminar talk titled 'CRISPR Cas9 genetic screens to ameliorate cellular stress in neurodegeneration'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.opdc.ox.ac.uk/seminars-events |
Description | OPDC Seminar 8 March 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Dr. Nicolas Tritsch (Neuroscience Institute and Marlene & Paulo Fresco Institute for Parkinson's & Movement Disorders, New York University, gave an online OPDC seminar talk titled, Modulation of striatal circuits by midbrain dopamine neurons |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/28ca76e2-e9fa-4ef1-a3c7-d23a9bf39852/ |
Description | OPDC Seminar 9 March 2020 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On behalf of of Professor Richard Wade-Martins, Dr Hélène Plun-Favreau, UCL Institute of Neurology gave a talk on Mitophagy: from genetics to biology, and back on 9 March |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | OPDC Seminar held on 18 May 2022 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 18 May 2022, Dr Nicole Calakos (Dept. of Neurology, Duke University, School of Medicine), gave an OPDC seminar talk titled, A hidden regulator of neuromodulation and motor learning: Protein synthesis by the integrated stress response (ISR) |
Year(s) Of Engagement Activity | 2022 |
URL | https://talks.ox.ac.uk/talks/id/d3183e00-517f-418f-be8c-3150129c7230/ |
Description | OPDC Seminar held on 22 June 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 22 June 2021, Dr Olga Corti gave an OPDC seminar titled, Mitophagy dysfunction in autosomal recessive Parkinson's disease: is it the whole story? |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/02973f03-653d-41da-bedf-cfedb5e8b829/ |
Description | OPDC Seminar held on 24 May 2022 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 26 May 2022, Dr Kevin McFarthing (Research Advisor, Parkinson's UK Oxford Branch) gave an in person OPDC seminar talk titled, 'The drug development landscape in Parkinson's'. |
Year(s) Of Engagement Activity | 2022 |
URL | https://talks.ox.ac.uk/talks/id/11a186f0-d507-49db-8355-9f6aa08ebcae/ |
Description | OPDC Seminar held on 25 January 2023 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 25 January 2023, Dr. Daniela Berg, (University Medical Center Schleswig-Holstein, Germany) gave an online OPDC seminar talk titled, 'Prodromal PD-definition and impact for clinical studies'. |
Year(s) Of Engagement Activity | 2023 |
URL | https://talks.ox.ac.uk/talks/id/88329935-b48d-4ff8-b8bf-e69f60fadc04/ |
Description | OPDC Seminar held on 27 February 2023 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 27 February 2023, Professor Malú Gámez Tansey (University of Florida) will give an OPDC seminar talk - title tbc. |
Year(s) Of Engagement Activity | 2023 |
URL | https://talks.ox.ac.uk/talks/persons/id/3d3d9b0c-14b6-4ef5-9734-30c1a3e3d2b6 |
Description | OPDC Seminar held on 27 June 2022 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 27 June, Dr. Mark R. Cookson (Laboratory of Neurogenetics, National Institute on Aging (NIA)) gave an OPDC seminar talk titled, 'The role of LRRK2 in familial and sporadic Parkinson's disease. |
Year(s) Of Engagement Activity | 2022 |
URL | https://talks.ox.ac.uk/talks/id/c248cab1-6fb4-45ee-a14d-1e53d3eb1b2f/ |
Description | OPDC Seminar held on 30 March 2023 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 30 March 2023, Professor Pascal Kaeser (Harvard Medical School) will give an OPDC online seminar talk titled, 'Mechanisms and Roles of Fast Dopamine Signaling'. |
Year(s) Of Engagement Activity | 2023 |
URL | https://talks.ox.ac.uk/talks/id/e623ef3c-aff1-4117-852e-93500d350276/ |
Description | OPDC Seminar held on 31 October 2022 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 31 October 2022, Suzanne Pfeffer, Ph.D. (Stanford University School of Medicine) gave an online OPDC seminar talk titled, 'LRRK2 kinase in Parkinson's disease: from single molecule to the brain'. |
Year(s) Of Engagement Activity | 2022 |
URL | https://talks.ox.ac.uk/talks/id/161e8a60-d515-4545-9ade-3f89b3413b00/ |
Description | OPDC Seminar held on 6 July 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 6 July 2021, Dr Mark Howe gave an OPDC seminar talk titled, 'Sub-second Striatum Neuromodulatory Signaling on Multiple Spatial Scales During Learning and Action'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/da6b9878-7df5-47b2-98f3-0e1cb10ee3ac/ |
Description | OPDC Seminar held on 6 July 2022 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 6 July 2022, Dr Clemens Scherzer (Harvard Medical School) gave an online OPDC seminar talk titled, 'Cell circuits, progression genetics, and the quest to solve Parkinson's with precision medicine'. |
Year(s) Of Engagement Activity | 2022 |
URL | https://talks.ox.ac.uk/talks/id/308dacef-951d-4fbb-980f-af68c03dd0ed/ |
Description | OPDC Seminar held on 7 December 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 7 December 2021, Dinos Meletis gave an OPDC seminar talk titled, 'Molecular and functional organization of the mouse striatum'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/9ab779f8-edc6-4043-adf2-e9a82a04aa5e/ |
Description | OPDC newsletter |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | In March 2022, the OPDC newsletter was circulated in hard copy and online. The Spring 2022 newsletter included: Updates from the discovery team on the UPP project, Introducing the Central Oxford Cohort Team, News for research participants, OPDC team update, Parkinson's UK walk, New laboratory facilities, Current OPDC research work and findings, Two major new Grants and Giving to OPDC |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.dpag.ox.ac.uk/files/research/opdc-newsletter-march-2022 |
Description | OPDC researchers welcome Parkinson's UK and the Oxford Branch committee |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | In March 2022, the Oxford Parkinson's Disease Centre (OPDC) hosted Caroline Rassell, Parkinson's UK Chief Executive; David Dexter, Associate Research Director; Trustee Board members, Gary Shaughnessy (Chair) and Sally Bromley; together with members of the Parkinson's UK Oxford Branch committee, for a visit to showcase the research being carried out in Oxford. |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.dpag.ox.ac.uk/opdc/news/latest/opdc-researchers-welcome-parkinson2019s-uk-and-the-oxford... |
Description | Online OPDC Seminar 10 December |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 10 December, Richard Youle, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland, USA, gave an online talk 'Mechanisms of Innate Immunity and Parkinson's Disease'. |
Year(s) Of Engagement Activity | 2020 |
Description | Online OPDC Seminar 12 October 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 12 October 2021, Dr Sreeganga Chandra gave an OPDC Seminar talk titled. 'Synaptic Vesicle Endocytosis and Parkinson's disease'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/043b029a-b6e5-4f8a-bd85-1bff8906b38d/ |
Description | Online OPDC Seminar 13 October |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 13 October, D. James Surmeier, Feinberg School of Medicine at Northwestern University, USA, gave an online talk on the 'Time to revise the classical model of basal ganglia dysfunction in PD: New insights from a novel, progressive mouse of mitochondrial complex I dysfunction'. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | Online OPDC Seminar 15 June |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | On 15 June, Tim Bartels, UK Dementia Research Institute (DRI), University College London (UCL) gave an online talk on the 'Selective brain region vulnerability in Parkinson's Disease is governed by a-Synuclein conformations'. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | Online OPDC Seminar 17 May 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 17 May 2021, Dr. Per Borghammer gave an OPDC seminar talk titled, 'Body-first & Brain-first Parkinson's disease - explaining motor asymmetry, non-motor subtypes, and dementia'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/055dec13-1a48-4068-94ee-ceb9b65ac2a5/ |
Description | Online OPDC Seminar 18 May |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 18 May, Vincenzo Bonifati, Erasmus University Medical Center, Rotterdam, gave an online talk with 'An update on the quest for genetic determinants in Parkinson's Disease'. & related diseases |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | Online OPDC Seminar 19 April 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Policymakers/politicians |
Results and Impact | On 19 APril 2021, Dr Anne Grünewald, Associate Professor at the University of Luxembourg gave an online OPDC seminar talk titled, 'Mitochondrial DNA at the interface between mitochondrial dysfunction and inflammation in Parkinson's disease'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/f8696cd5-aa1c-4e2c-ada5-a4c08976364b/ |
Description | Online OPDC Seminar 20 April |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 20 April, Daniel Otzen, Interdisciplinary Nanoscience Center (iNANO), Aarhus University, gave an online talk on the 'Targeting cytotoxic alpha-synuclein oligomers in Parkinson's Disease' |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | Online OPDC Seminar 22 September |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 22 September, Jacqueline Burré, Brain and Mind Research Institute at Weill Cornell Medicine, USA gave an online talk on 'Function and Dysfunction of Synucleins - Membranes Matter'. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | Online OPDC Seminar 6 July |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | On 6 July, Madeline Lancaster, MRC, Laboratory of Molecular Biology, Cambridge, gave an online talk on 'Exploring human brain structure and function using cerebral organoids'. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | Online OPDC Seminar 9 March 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 9 March, 2021,Dr Nicolas Tritsch, Neuroscience Institute and Marlene & Paulo Fresco Institute for Parkinson's & Movement Disorders, New York University. gave an online talk 'Modulation of striatal circuits by midbrain dopamine neurons' |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.opdc.ox.ac.uk/seminars-events |
Description | Online OPDC Seminar 9 November |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 9 November, Valina Dawson, John Hopkins University School of Medicine, Baltimore, Maryland, USA gave an online talk 'Decoding Parkinson's Disease: New Therapeutic Opportunities'. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/_asset/file/opdc-seminars-2020.pdf |
Description | Online OPDC Seminar on 22 September 2021 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 22 September 2021, David Rubinsztein gave an OPDC seminar talk, titled, 'Autophagy and neurodegeneration'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/e89c9fb6-1634-45f8-86c0-f43eb5fe22c8/ |
Description | Oxford Drug Discovery Institute Research Symposium, Oxford UK |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | In September 2022, Professor Richard Wade-Martins gave a talk at the Oxford Drug Discovery Institute Research Symposium, Oxford UK |
Year(s) Of Engagement Activity | 2022 |
Description | Oxford PD UK |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | I spoke at a meeting of the Oxford Parkinson's UK branch |
Year(s) Of Engagement Activity | 2017 |
Description | Oxford PD UK Carol Service and walk 2016 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Attended and supported Parkinson's UK Oxford Carol service and sponsored walk 2016 |
Year(s) Of Engagement Activity | 2016 |
Description | Oxford Parkinson's Disease Centre pays tribute to one of its loyal fundraisers |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Researchers from the Oxford Parkinson's Disease Centre (OPDC) paid tribute to Bobbie Coelho, one of the OPDC's long term fundraisers who has decided to take a step back from active fundraising activities. A video message was created from OPDC researchers thanking her for all the amazing work she has done towards funding Parkinson's research over the years. Together with a bouquet of flowers, they also gave her an engraved glass OPDC honorary award which was presented to her 'in recognition of outstanding fundraising to support research into Parkinson's'. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.opdc.ox.ac.uk/oxford-parkinson-s-disease-centre-pays-tribute-to-one-of-its-loyal-fundrai... |
Description | Oxford Parkinson's Research Day |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | On Tuesday 29th November 2022, Professor Richard Wade-Martins and Professor Michele Hu from the Oxford Parkinson's Disease Centre (OPDC) hosted the Oxford Parkinson's Research Day at the Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford. Professor Irene Tracey, Vice-Chancellor Elect of the University of Oxford, Warden of Merton College and Professor of Anaesthetic Neuroscience, opened the days' proceedings. The programme was split across four sessions covering a wide range of translational work into Parkinson's: "Clinical Research into Parkinson's", "Translational models of Parkinson's", "Molecular Mechanisms and related biomarkers", and "Cellular models and target discovery" describing work across the University and from our collaborators. There were three invited keynote speakers:- Professor Masud Husain, University of Oxford. Masud Husain is Professor of Neurology & Cognitive Neuroscience at the University of Oxford. He leads the Neurological Conditions theme of the NIHR Oxford Biomedical Research Centre and is Editor-in-Chief of the publication, Brain. Together with Cornelia van Duijn, he leads Dementia Research Oxford. Professor Husain's presentation was titled, "When the spark goes out: the neurology of motivation and apathy". Professor Miratul Muqit, University of Dundee. Miratul Muqit is Professor (Clinical) MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee. His laboratory studies the protein kinase, PTEN-induced kinase 1 (PINK1) in which loss of function mutations cause Parkinson's disease. Professor Muqit presented, "Decoding Mitochondrial Damage Response Pathways linked to Parkinson's disease". Professor Sonia Gandhi, UCL. Sonia Gandhi is Professor of Neurology, Clinical and Movement Neurosciences at Queen Square Institute of Neurology, University College London. Professor Gandhi's laboratory works on the cellular and molecular biology of Parkinson's and her talk title was, "Thinking big to see small: from nanoscale to mesoscale resolution in Parkinson's". In addition to the talks, there were 37 poster presentations on display throughout the day. The event closed with Dr Kevin McFarthing, Research Advisor, Parkinson's UK Oxford Branch, presenting the best poster award voted for by all attendees. The prize awarded for the best poster was won by DPhil student Victor (Shijun) Yan, from the Molecular Neurodegeneration Research Group, University of Oxford, for his poster titled, 'a-synuclein in L1CAM-Positive Serum Extracellular Vesicles as a predictive biomarker for Parkinson's disease pathology'. Selected talks included Charmaine Lang, Peter Kilfeather, Sally Cowly, Michael Lawton, Becky Carlyle, George Tofaris, Laura Parkkinen, Katherine Brimblecombe, Ira Milosovic |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.dpag.ox.ac.uk/opdc/oxford-parkinson2019s-disease-centre-host-the-2022-oxford-parkinson20... |
Description | Parkinson's UK Oxford Walk |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | On 22 September, Professor Richard Wade-Martins & Dr Laura Parkinnen took part in the Parkinson's UK Oxford Walk. |
Year(s) Of Engagement Activity | 2019 |
Description | Parkinson's UK walk |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Supporters |
Results and Impact | Went on a sponsored walk Raised money and awareness |
Year(s) Of Engagement Activity | 2014,2015 |
Description | Parkinson's public awareness talk at Green Templeton College |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | On 11 September 2019, Professor Wade-Martins gave a public awareness talk about Parkinson's Disease at Green Templeton College |
Year(s) Of Engagement Activity | 2019 |
Description | Poster and flash talk at the International Ataxia Research Conference (AIRC) November 19 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Conference abstract, poster presentation, "A CRISPR/Cas9 genome-wide screen identify DDX6 as a novel regulator of FXN expression in Friedreich's ataxia", International Ataxia Research Conference 2019, Washington D.C, United States. Attended by Gabriela Vilema Enríquez & Professor Richard Wade-Martins |
Year(s) Of Engagement Activity | 2019 |
URL | http://iarc2019.org/ |
Description | Poster at Advances in Neurodegenerative Disease Research and Therapy/New Frontiers in Neuroinflammation Keystone Conference, Colorado USA |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Nora Bengoa-Vergniory poster "Tau-proximity ligation assay detects pathology ahead of tau neurofibrillary tangles in Alzheimer's disease" As the world population ages, neurodegenerative diseases are becoming the new epidemic in both developed and developing countries. Progress made in human genetics has revealed increasingly more disease-associated genes for Alzheimer's disease (AD), Parkinson's disease (PD), Frontotemoral dementia (FTD), amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. These discoveries have linked neurodegenerative diseases with several common key biological processes that have so far been under-studied, including RNA metabolism, protein trafficking and innate immune responses. By focusing on these emerging areas in neurodegenerative disease research, this conference seeks to challenge the current research paradigms and to inspire in-depth discussion and exploration. The program assembles leaders from various fields to facilitate interactions between groups using diverse approaches, by providing a platform to cross-fertilize ideas and to encourage new collaborations that could lead to novel mechanisms and therapeutic targets against neurodegenerative diseases. |
Year(s) Of Engagement Activity | 2018 |
URL | http://www.keystonesymposia.org/18Z3 |
Description | Poster presentations at the Dementia Research Day hosted by the ARUK Thames Valley Network |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | On 1st July 2022, members of the Wade-Martins ab presented posters at the 2022 Dementia Research Day hosed by the ARUK Thames Valley network. They included Tara Diviney, Jack Connor, Naroa Ibarra Aizpurua, Remya Nair, Kaitlyn Cramb, Ajantha Abey, Elena Britti, and Sarah Franks. |
Year(s) Of Engagement Activity | 2022 |
Description | Poster presentations at the Oxford Parkinson's Research Day |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | On 29th November 2022, members of the Wade-Martins ab presented posters at the Oxford Parkinson's Research Day. They included Naroa Ibarra Aizpurua, Mahmoud Bassal, Elena Britti, Sarah Franks, Quyen Do, Ajantha Abey, Helle Begetofte, Tara Diviney, Remya Nair, William McGuinness, Rachel Heon Roberts, Kaitlyn Cramb, Maria Claudia Caiazza, Elliot Mock, Peter Kilfeather and Hugo Fernandes. |
Year(s) Of Engagement Activity | 2023 |
Description | Presentation at the British Pharmacological Society Annual Conference, Online meeting |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | In October 2020, Prof. Richard Wade-Martins gave a presentation at the British Pharmacological Society Annual Conference. Online meeting |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.bps.ac.uk/news-events/news |
Description | Presentation at the conference; Grand Challenges in Parkinson's Disease, Van Andel Institute, Grand Rapids, MI |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | In October 2021, Prof. Ricahrd Wade-Martins will be giving a presentation at the conference; Grand Challenges in Parkinson's Disease, Van Andel Institute, Grand Rapids, MI |
Year(s) Of Engagement Activity | 2021 |
URL | https://grandchallengesinpd.org/ |
Description | Presentation poster session at ADPD in Barcelona in March |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Maria Claudia Caiazza will be presenting her data in a poster session at the AD/PD conference in Barcelona between 15-20th March. |
Year(s) Of Engagement Activity | 2022 |
URL | https://adpd.kenes.com/ |
Description | Presented a poster titled, 'TPC2 Expression and Function in Models of Parkinson's disease' at the Oxford Neuroscience Symposium |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | In March 2023, Johanna Hoffman presented a poster titled, 'TPC2 Expression and Function in Models of Parkinson's disease' at the Oxford Neuroscience Symposium. |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.neuroscience.ox.ac.uk/about/oxford-neuroscience-symposium |
Description | Presented a poster titled, 'TPC2 Expression and Function in Models of Parkinson's disease' at the Parkinson's Disease ECR UKDRI Manchester conference |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | In March 2023, Johanna Hoffman presented a poster titled, 'TPC2 Expression and Function in Models of Parkinson's disease' at the first in-person Parkinson's disease Early Career Researcher (ECR) meeting at the Core Technology Facility, University of Manchester. |
Year(s) Of Engagement Activity | 2023 |
Description | Prof Ricahrd Wade-Martin gave a talk at CRISPR in Drug Discovery, ELRIG Meeting, Babraham Institute, Cambridge |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | On 2nd March, Prof Richard Wade-Martins will give a talk titled, iPSC models of Parkinson's: from disease mechanisms to target discovery |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.elrig.org/portfolio/crispr-in-drug-discovery-2022/ |
Description | Prof Richard Wade-Martins gave a seminar talk at the Dementia Research Oxford Seminars series |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 25 November 2021, Prof Richard Wade-Martins gave a seminar talk titled, 'Understanding tau and Abeta biology in health and disease'. |
Year(s) Of Engagement Activity | 2021 |
URL | https://talks.ox.ac.uk/talks/id/a2bcdeb9-f2f2-477b-a327-6bd0a6de0545/ |
Description | Professor Richard Wade-Martin gave a talk at the Longevity Forum at Oriel College, Oxford |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | On 12 November, Professor Richard Wade-Martin gave a talk at the Science Summit, Longevity Forum at Oriel College, Oxford |
Year(s) Of Engagement Activity | 2019 |
URL | https://thelongevityforum.com/the-longevity-week/ |
Description | Professor Richard Wade-Martins gave a talk at the Oxford Stem Institute Symposium 2019 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | on 18 September, Professor Richard Wade-Martins gave a talk at the Oxford Stem Institute Symposium 2019. Stems Cell: From Mechanism to Therapy |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.stemcells.ox.ac.uk/home |
Description | Professor Richard Wade-Martins gave an ARUK Target Drug Discovery talk along with Dr George Tofaris |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On 12 November, Professor Richard Wade-Martins gave an ARUK Target Drug Discovery talk along with Dr George Tofaris |
Year(s) Of Engagement Activity | 2019 |
Description | Profile on Nora Bengoa-Vergniory and workplace |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Recorded in 2019, Dr Nora Bengoa-Vergniory was filmed over a day for a Basque TV programme called "Vascos por el mundo". She was shown in her daily workplace inside the Wade-Martins lab. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.eitb.eus/es/television/programas/vascos-por-el-mundo/ |
Description | Pub quiz in aid of Parkinson's Research |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Siv Vingill, Melanie Witt, Dayne Beccano-Kelly, Nora Bengoa-Vergniory and Melanie Witt took part in pub quiz held at the Barleycorn pub near Andover raising funds for Parkinson's research in Oxford. They met with supporters and talked about their work. |
Year(s) Of Engagement Activity | 2018 |
URL | https://www.opdc.ox.ac.uk/oxford-parkinson-s-disease-centre-members-raise-funds-for-their-research-a... |
Description | Pub quiz in aid of Parkinson's Research |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Richard Wade-Martins, Dayne Beccano-Kelly, Nora Bengoa-Vergniory, Marta Madureira, Brent Ryan, Matthieu Trigano, Siv Vingill, along with OPDC administrator, Lorraine Dyson, travelled to the Royal Oak, Goodworth Clatford in Andover to take part in a quiz night in aid of Parkinson's research. They met with supporters and talked about their work. OPDC supporters Bobbie Coelho, Mary Doherty and Dawn Huntly presented a cheque for £2000 to Professor Richard Wade-Martins to support the work being carried out by the OPDC into Parkinson's Disease. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.opdc.ox.ac.uk/oxford-parkinson-s-disease-centre-support-charity-christmas-pub-quiz |
Description | Researchers participate in the annual Walk for Parkinson's in Oxford |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | On Sunday 19th September, a team of researchers and supporters from the OPDC & Wade-Martins Group took part in the annual Walk for Parkinson's in Oxford organised by Parkinson's UK, in conjunction with the Parkinson's UK Oxford Branch Members of the OPDC completed either the 6 or 2 mile walk on the tracks and paths through the woodland at Wytham Woods to help raise funds towards vital research into Parkinson's Disease. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dpag.ox.ac.uk/opdc/news/latest/opdc-participate-in-the-annual-walk-for-parkinson2019s-ox... |
Description | School visit to give a talk |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | On 18th January, Naroa Ibarra Aizpurua gave a talk at the OIBC Biology Symposium held at St Edward's School in Oxford for 6th form students. |
Year(s) Of Engagement Activity | 2023 |
URL | http://stedwardsoxford.org |
Description | Seminar talk at the AstraZeneca Neurosciences, Cambridge UK |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | In November 2020, Prof Richard Wade-Martins gave a talk at the AstraZeneca Neurosciences, Cambridge UK |
Year(s) Of Engagement Activity | 2020 |
URL | https://azneuro.com/ |
Description | Seminar talk at the Biomedical Research Foundation Academy of Athens, Greece |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | In March 2020, Prof. Richard Wade-Martins gave a seminar talk at the Biomedical Research Foundation Academy of Athens, Greece |
Year(s) Of Engagement Activity | 2020 |
URL | http://www.bioacademy.gr/events |
Description | Set up of new Parkinson's UK research seminar series |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | During the COVID-19 pandemic, Natalie Connor-Robson helped set up and organise a new online Parkinson's UK seminar series for researchers. |
Year(s) Of Engagement Activity | 2020 |
Description | Social media post and video to celebrate Women in Science Day |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In February 2022, researchers from the Wade-Martins lab participated in a video celebrating Women in Science day |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.youtube.com/watch?v=U0yGdxZ7k2A |
Description | Social media post as Naroa Ibarra Aizpurua won an online image competition for her ICC image of iPSC-derived midbrain neuron & astrocyte co-cultures. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In November 2021, Naroa Ibarra Aizpurua won an online image competition for her ICC image of iPSC-derived midbrain neuron & astrocyte co-cultures. |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/PKILifeScience/status/1456633666193481735 |
Description | Social media post as part of DPUK advent calendar featuring Professor Richard Wade-Martins |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In December 2021, there was a social media poster on Day 22 of #DPUKadvent featuring Prof Richard Wade-Martins Richard is Professor of Molecular Neuroscience @UniofOxford and principle investigator of @WadeMartinsLab at @OxfordPDCentre. Richard also leads DPUK's Stem Cell Network - read more about it here: https://dementiasplatform.uk/research-hub/stem-cell-network |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/DementiasUK/status/1473616556676554752 |
Description | Social media post highlighting posters featured in BNA 2021. |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Social media post highlighting the poster displayed at BNA 2021 by Nora Bengoa-Vergniory, Brent Ryan, Kaitlyn Cramb, William McGuinness, Bryan Ng, and Maria Claudia Caiazza |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/OxfordPDCentre/status/1430823145347420160 |
Description | Social media post to announce new OPDC website |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In March 2021, a new OPDC website was announced and shared via social media. |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/OxfordPDCentre/status/1376504552057417733 |
Description | Social media post to highlight World Parkinson's Day |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | On 11 April, a social media post was shared highlighting World Parkinson's Day and promoting the new OPDC website. |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/OxfordPDCentre/status/1381163333286572033 |
Description | Social media post to highlight new video |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | We shared a new video titled, 'The immunological side of neurodegeneration: a focus on #Parkinson's disease' by Stefania Guissani |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/OxfordPDCentre/status/1479042121009188866 |
Description | Social media post to promote the stem cell work of PhD researcher Ajantha Abey |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In October 2021, there was a social media post to promote the stem cell work of PhD researcher Ajantha Abey and link to news item |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dementiasplatform.uk/research-hub/stem-cell-network/meet-the-phd-student-investigating-w... |
Description | Social media post to promote the stem cell work of PhD researcher Naroa Ibarra Aizpurua |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In October 2021, there was a social media post to promote the stem cell work of PhD researcher Naroa Ibarra Aizpurua and link to news item |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dementiasplatform.uk/research-hub/stem-cell-network/can-a-type-of-supportive-brain-cell-... |
Description | Social media post to promote the stem cell work of PhD researcher Quyen Do |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In October 2021, there was a social media post to promote the stem cell work of PhD researcher Quyen Do and link to news item |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dementiasplatform.uk/research-hub/stem-cell-network/growing-mini-brains-to-study-parkins... |
Description | Social media post welcoming new staff and students to the Wade-Martins lab |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Throughout 2022, social media messages were posted welcoming news members of the Wade-Martins lab and linking through to the profile pages on the website. |
Year(s) Of Engagement Activity | 2022 |
Description | Symposium Speaker at the Federation of Latin American and Caribbean Neuroscience |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | In September 2022, Professor Richard Wade-Martins was a Symposium Speaker at the Federation of Latin American and Caribbean Neuroscience |
Year(s) Of Engagement Activity | 2022 |
Description | Taking part in the Poster Day 'A Year of Progress' by 2nd Year Graduate Students |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | On the 18th of November, Naroa Ibarra Aizpurua created a poster presentation to share her research at the 2021 Poster Day 'A Year of Progress' by 2nd Year Graduate Students |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.dpag.ox.ac.uk/news/winners-of-the-dpag-student-poster-day-2021-announced |
Description | Talk at the Biomedical Research Foundation Academy of Athens, Greece March 2020 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Professor Richard Wade Martins gave a talk at the Biomedical Research Foundation Academy of Athens, Greece in March 2020 |
Year(s) Of Engagement Activity | 2020 |
URL | http://www.bioacademy.gr/about |
Description | Talk at the HOPE Conference for Parkinson's Research, Paris Jan 2020 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Professor Richard Wade-Martins gave a talk at the HOPE Conference for Parkinson's Research, Paris 29-31 Jan 2020 |
Year(s) Of Engagement Activity | 2020 |
URL | https://hope2020.sciencesconf.org/ |
Description | Talk at the PerkinElmer UK High-Content Screening User Group Meeting |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | On 29th September 2022, Naroa Ibarra Aizpurua gave a talk at the PerkinElmer UK High-Content Screening User Group Meeting in Madrid. |
Year(s) Of Engagement Activity | 2022 |
Description | Talk at the University College London, IoN Movement Disorders Centre Inaugural Symposium: |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | On 11 March, Professor Richard Wade-Martins gave a talk at the University College London, IoN Movement Disorders Centre Inaugural Symposium: Launch of the UCL Movement Disorders Centre |
Year(s) Of Engagement Activity | 2020 |
URL | http://www.ucl.ac.uk/ion/events/2020/mar/ucl-ion-movement-disorders-centre-inaugural-symposium-launc... |
Description | Talk at the University of Bath, UK |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Postgraduate students |
Results and Impact | In February 2023, Professor Richard Wade-Martins was invited to give talk at the University of Bath, UK |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.bath.ac.uk/ |
Description | Times Radio interviews following publication of the Times article "Brain tweezers could treat Parkinson's" |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | In September, Professor Richard Wade-Martins & Dr Nora Bengoa-Vergniory held a Times Radio discussion on novel therapeutic approaches to Parkinson's following the publication of the Times article "Brain tweezers could treat Parkinson's" https://www.thetimes.co.uk/article/brain-tweezers-could-treat-parkinsons-sw2sjdnq9#:~:text=Minuscule%20brain%20%E2%80%9Ctweezers%E2%80%9D%20could%20treat,clumps%2C%20by%20pulling%20them%20apart |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.thetimes.co.uk/article/brain-tweezers-could-treat-parkinsons-sw2sjdnq9#:~:text=Minuscule... |
Description | Twitter post to celebrate International Women in Science Day 2021 |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | On 11 February 2021, the Wade-Martins posted a photo to celebrate International Women in Science Day 2021. |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/WadeMartinsLab/status/1359831629653553154 |
Description | Twitter post to highlight April issue and front cover of Trends in Biochemical Sciences & featuring the review article "Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy" |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | In March 2021, a Tweet was posted to highlight April issue and front cover of Trends in Biochemical Sciences & featuring the review article "Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy" |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/OxfordPDCentre/status/1370335875738042376 |
Description | UCL Queen Square Movement Disorders Centre Symposium |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | On 9 June 2022, Professor Richard Wade-Martins gave a talk at the UCL Queen Square Movement Disorders Centre Symposium |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.ucl.ac.uk/ion/events/2022/jun/ucl-queen-square-movement-disorders-centre-symposium |
Description | Video posted online & shared via social media to celebrate World Alzheimer's Day on 21 September 2022 |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | To coincide with World Alzheimer's Day on 21 September 2022, a video was posted online and shared on social media with an inside look into the Wade-Martins Laboratory. |
Year(s) Of Engagement Activity | 2022 |
URL | https://youtu.be/21es6CO8EkQ |
Description | Video posted online & shared via social media to celebrate World Parkinson's Day on 11 April 2022 |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Professor Richard Wade-Martins partipated in a video that was posted online & shared via social media to celebrate World Parkinson's Day on 11 April 2022 |
Year(s) Of Engagement Activity | 2022 |
URL | https://youtu.be/VAPvuGtT5ek |
Description | Visit to Parkinson's UK Aylesbury Branch |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | On 19/2/22, Dr Brent Ryan spoke to the Aylesbury Parkinson's UK group at their AGM on our work to find new drugs for Parkinson's |
Year(s) Of Engagement Activity | 2022 |
Description | Website article commemorating 100 years of women in science, featuring DPhil student; Naroa Ibarra Aizpurua |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | In October 2020, Naroa Ibarra Aizpurua, DPhil student, was featured in an article commemorating 100 years of women in science, where she discussed her motivation to apply to the Oxford and the Wade-Martins lab. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.dpag.ox.ac.uk/news/100-years-of-oxford-degrees-for-women |
Description | Wellcome Trust Collaborators meeting on Tuesday 6th September |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | On 6th September the OPDC hosted a Wellcome Trust Collaborators meeting. It included talks from representatives from the Liss lab (University of Ulm), Kittler lab (UCL) , Magill Lab (UoO), Wade-Martins lab(UoO), and the Cragg lab (UoO). The programme included a poster session. Posters included form the Wade-Martins lab; Remya Raghavan Nair, Kaitlyn Cramb, Elena Britti, Benjamin Vallin, Sarah Franks, Quyen Do, and Helle Bogetofte |
Year(s) Of Engagement Activity | 2022 |
Description | Winner of the PerkinElmer "Think Neuro Art Image Competition" |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Naroa Ibarra Aizpurua was the Winner of the PerkinElmer "Think Neuro Art Image Competition" (PerkinElmer Life Sciences on Twitter: "Thanks to everyone who submitted designs for our #ThinkNeuroArt image contest. We're wowed by the scientific & artistic abilities of our customers! Congratulations to our winner, @NaroaIbaAiz for her ICC image shown here, of iPSC-derived midbrain neuron & astrocyte co-cultures. |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/PKILifeScience/status/1456633666193481735 |
Description | Women in Science Day |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | To celebrate Women in Science day, researchers from the Wade-Martins lab contributed to a Kavli Institute social media posts and gave an interview for the hard copy booklet |
Year(s) Of Engagement Activity | 2023 |
URL | https://twitter.com/KavliOxford/status/1623637841204117505 |
Description | presentation to Henley on Thames Parkinson's UK branch |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | On 26 May 2021, Nora Bengoa-Vergniory gave a presentation about her research to the Henley on Thames Parkinson's UK local branch |
Year(s) Of Engagement Activity | 2021 |
URL | https://twitter.com/OxfordPDCentre/status/1397823354405634049 |
Description | visit to local primary school |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | On 19th June, a team of Unit members went to St Ebbe's C. of E. (Aided) Primary School in central Oxford, where they visited Year 6 pupils and their teachers to help them learn more about science, researchers, and how the brain works to control memory and movement. Pupils were first given a brief introduction to the work of the Medical Research Council and the MRC Brain Network Dynamics Unit. Pupils, teachers and Unit members then engaged in a range of interactive discussions and hands-on activities that included looking at nerve cells under a microscope, reporting on observations by making model cells, measuring electrical activity from muscles to control a robotic claw, comparing the brains of different vertebrates, discovering different types of memories, and using a game version of a brain-machine interface. |
Year(s) Of Engagement Activity | 2019 |
URL | https://www.mrcbndu.ox.ac.uk/news/unit-goes-out-local-primary-school-mrc-festival-medical-research |